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Abstract
Substance use disorders cause significant neurological damage, cognitive impairment,
and maladaptive behaviors that negatively affect a person’s quality of life. The purpose of
this study was to explore the effect gender and primary drugs have on locus of control.
Generalized expectancy theory helped to explain the behavior of patients diagnosed with
substance use disorders and their inability to control ongoing drug use. The research
question focused on to what extent drug-related locus of control scores differ by primary
drug (narcotic vs. stimulant), gender (male vs. female), and their interaction. Data
measuring locus of control from 553 participants provided a subset of 410 participants
who identified narcotics or stimulants as their primary drug. A 2x2 full factorial ANOVA
was conducted. The results of this study indicated there is a significant interaction
between primary drug use and gender. The results could have positive social change
implications for the addiction field because of the value of understanding the
interdependency of internal-external thought processes related to drug use, the ability to
change stigma associated with addiction and gender, and the value of understanding the
need for individualized treatment as locus of control shifts from external to internal. It is
recommended that the drug-related locus of control instrument become part of treatment
protocol along with evidence-based interventions.
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Chapter 1: Introduction to the Study
The Substance Abuse and Mental Health Services Administration (SAMHSA,
2015) reported the use of opioids, hallucinogens, stimulants, cannabis, tobacco, and
alcohol causes significant cognitive, behavioral, and social impairments, and negatively
affects a person’s quality of life. Physiological and psychological dependence on foreign
chemicals not naturally produced in the body was the previous definition of substance
abuse. In the updated edition of the Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-V), terminologies such as substance abuse or dependence
were replaced with substance use (American Psychiatric Association [APA], 2013).
Disruptions in family structure and harmony, legal or health issues, and adverse influence
on employment advancements or educational achievements are elements that were
identified and diagnosed as an addiction due to substance abuse or dependence (Bao et
al., 2009; Caan, 2012; Gifford & Humphreys, 2007; Grant, Potenza, Weinstein, &
Gorelick, 2010). Now, according to DSM-V, functionality associated with substance use
is the major focus of a substance abuse disorder diagnosis, along with the degree of
impairment. According to Cann (2012) and Kreek, Nielsen, Butelman, & LaForge
(2005), substance use disorders affect not only the individual’s quality of life, but that of
other citizens on a local, state, and national level. Social service providers have
responded to increased needs for shelter and food, along with physical and mental health
services based on the inability of individuals with a substance use disorder to sustain
themselves in the community without additional resources. Medical professionals have
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been confronted with reduced resources based on drug related treatment issues that
included injuries, overdoses, and diseases such as Human Immunodeficiency Virus and
Acquired Immunodeficiency Syndrome. The overuse of various substances also
contributed to emotional, mental, and psychological impairments such as psychosis,
depression, and anxiety, which drained scarce resources of mental health providers.
Substance users pushed the capacity of the criminal justice system as facilities tried to
accommodate drug-related criminals. Most important, the United States suffered from the
loss of productive workers, as substance users lack the capacity to perform in
employment and educational settings.
The multiple repercussions associated with substance abuse left the public with
negative opinions about people with a substance use disorder. The stigma attached to
those suffering from substance use disorders contributed to the development of a social
movement. The movement included the need to shift public opinion away from negative
association related to addiction. Davidson et al. (2008) argued the omission of the word
addict from the treatment process would help shift thought processes toward positive
interventions such as patient empowerment and patient-centered care. Karim and
Chaudhri (2012) and McLachlan and Starkey (2012) suggested redefining the traditional
view of people with addiction and providing the most appropriate treatment such as an
individualized assessment tool. The Drug-Related Locus of Control (DRLOC) scale is an
individualized assessment tool that targets the patient’s needs and supports the
implementation of patient-centered care (Hall, 2001). By understanding the score
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generated by the DRLOC scale, patients could recognize their addictive thought
processes in order to control their behavior, thereby minimizing the negative effect
addiction has on medical, mental health, legal and family systems, and the stigma
associated with substance use disorders.
Despite Davidson et al.’s (2008), Karim’s and Chaudhir’s (2012), and
McLachlan’s and Starkey’s (2012) efforts to change the negative opinions and social
stigma related to people diagnosed with substance use disorders, drug addiction
continued to plague the United States and other countries throughout the world and have
reached an epidemic level (Baird, 2015; Rollins, 2016; Worley, Heinzerling, Shoptaw, &
Ling, 2015). The United Nations Office on Drugs and Crime (UNODC, 2015a),
documented an estimated 162 to 324 million people, globally, reported the use of some
form of illicit drugs. Mennis, Stahler, and Baron (2012) reported 205 million people
worldwide abused drugs during 2012. In the United States, the prevalence of addiction
continued to negatively affect the country with 23.9 million Americans who reported the
use of illegal drugs between 2008 to 2012 (Cummins, Nadorff, & Kelly, 2009;
SAMHSA, 2013a).
In California, each year from 2010 to 2014, approximately 876,000 residents
reported the use or abuse of illicit drugs (SAMHSA, 2015). SAMHSA (2013a) reported
947,000 people in California abused illicit drugs in 2012. However, less than 115,000 of
the 947,000 people received some form of treatment. The following year, California
reported 169,875 admissions into various treatment programs with 136,654 initial
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admissions and 33,221 readmissions, indicating individuals often sought treatment
multiple times (California Department of Alcohol and Drugs Program [CDADP], 2013).
The CDADP (2013) also found Methamphetamine was the most commonly reported
primary drug of choice in the state, at a rate 13% higher than heroin.
Substance use disorders involve complex neurological changes. They cause
neurobiological reactions at a cellular level where molecules create structural changes
and shifts in behavior . Genetics and environmental factors contribute to maladaptive
behaviors and impaired thought processes, from the begin stage of drug use, to the
escalation of drug abuse, and then finally addiction (CDADP, 2013; Kreek et al., 2005;
SAMHSA, 2013a; UNODC, 2015a). The issues involved with substance use disorders
warrant the need for ongoing studies from multiple disciplines, including research in the
areas of social science, neuroscience, behavioral science, and cognitive science.
The development and use of assessment instruments helped to identify and treat
addictive behaviors (Ersche, Turton, Croudace, & Stochl, 2012; Hall, 2001; Neto & True,
2011). Administering assessment instruments directly related to substance abuse and
assisted clinicians in determining a patient’s readiness toward recovery, which helped
guide the practitioner to implement one or multiple evidence-based treatment
interventions. Treatment programs that administer the DRLOC assessment instrument
during admission, while in treatment, and toward the end of services could be beneficial
for measuring treatment success.
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In Chapter 1, I provide the background of this study, along with an introduction to
the development of the DRLOC scale and the original Internal-External Locus of Control
(I-E LOC) instrument. Additionally, I identify the purpose and social significance of
conducting the study, along with the methodology, hypotheses, and research questions. I
also offer details concerning generalized expectancy theory, which I used for my
theoretical foundation. Included in this chapter are the operational definitions of terms,
along with the assumptions, limitations, and scope of the study. Finally, I provide the
etiology of addiction and the significance and nature of the study, along with a deeper
understanding of the social implications related to drug use.
Background of the Study
Addiction is a chronic relapsing disease (Davidson et al., 2008; Gifford &
Humphreys, 2007; Grant et al., 2010; Vohs & Baumeister, 2009). There are two types of
addiction: Chemical addictions related to foreign chemicals introduced into the body and
behavioral or process addictions, developed from patterns of impulsive and compulsive
behaviors (Buckland, 2008; Caan, 2012; Grant et al., 2010; Karim & Chaudhri, 2012;
Shor & Levit, 2012). Both types of addictions share commonly identified
biopsychosocial and behavioral features in the areas of development, maintenance,
treatment, and recovery (Grant et al., 2010; Leeman & Potenza, 2013; McLachlan &
Starkey, 2012). Addiction is a mental health disorder that presents with very complex
behaviors and tends to cooccur with other mental health disorders (Caan, 2012; Carlson
& Larkin, 2009; Congdon & Canli, 2008).
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Over several decades, substance use increased (UNODC, 2015a; SAMHSA,
2012). The UNODC monitored and annually reported drug activities from around the
world. In 2012, 162 to 324 million people used illegal drugs (UNODC, 2015a). This
number reflected the increased number of entries into treatment for substance use
disorders over the past 10 years. California is one state where the availability of treatment
continued to rise (CDADP, 2013).
Ongoing drug use may be the result of personality traits influenced by impulsivity
that caused addictive behaviors to develop (Caselles, Mico, & Amigo, 2010; Cyders et
al., 2007; Whiteside & Lynam, 2001). People’s belief systems also influenced ongoing
drug use and are directly related to their ability to obtain abstinence through treatment
(Hall, 2001; Rotter, 1966).
There are numerous commonalities across a wide range of substance use disorders
that present with similar cognitive, neurological, and physiological symptoms. Substance
use disorders also share similar behavioral characteristics in terms of etiology,
functionality, and response to treatment interventions (Gifford & Humphreys, 2007;
Grant et al., 2010). Individualized instruments that measure specific impulsive behaviors
associated with seeking out and obtaining drugs and instruments that measure thought
processes related to drug use are tools practitioners have used to help identify triggers
(Cyders et al., 2007; Ersche et al., 2012; Hall, 2001; Whiteside & Lynam, 2001). I seek to
understand whether the score generated from the DRLOC scale is influenced by gender
and narcotic or stimulant (cocaine, crack, amphetamine, or Methamphetamine) abuse.

7
The stigma of seeing patients as addicts and not associating their addictions with a
neurological disease resulted in the need to advocate for social change (Davidson et al.,
2008). Davidson et al. (2008) and Larkin, Wood, and Griffiths (2006) encouraged
individuals and organizations in the healthcare field to demonstrate a positive shift in the
words they chose to use and the way they treated patients with addictions. Davidson et al.
(2008) further encouraged practitioners to become more person-centered.
Person-centered regimens focus on patients as individuals, thereby providing
customized treatment plans (Rogers, 1992). After the introduction of Rogers’ theory of
patient-centered care, which allowed for individualized treatment plans and research
approaches and consisted of six components, Kirschenbaum and Jourdan (2005)
narrowed the six initial elements of patient-centered care down to three main
components: Empathy, unconditional positive regard, and positive congruency.
Incorporating patient-centered care across mental health and addiction settings could help
diminish the stigma associated with substance use disorders (Kirschenbaum & Jourdan,
2005).
For this study, I examined chemical addictions, specifically those related to
narcotic and stimulant (cocaine, crack, amphetamine, and Methamphetamine) abuse. The
criterion related to these addictions and diagnoses are under the category of substance use
disorders in the DSM-V. As noted by Caan (2012) and Congdon and Canli (2008), the
development of addictive behaviors is complex. Rotter's generalized expectancy theory
has been applied in the field of addiction to explain how past positive or negative
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experiences determined whether people generalize their current experiences or reinforced
them using internal or external beliefs, which placed value on similar experiences in the
future. Rotter (1966) theorized that if people expected that similar situations or events
would bring about a similar outcome, then impulsive people would respond according to
the outcome they expected to occur. How much control people felt they had over similar
outcomes determined how they responded (Rotter, 1966). Rotter and Mulry (1965)
termed this belief system locus of control.
Locus of control (LOC) has two constructs. The first construct described people
who have an internal LOC. People with an internal LOC believe they had some control
over the outcome of an event or situation regardless of the positive or negative result. If
people believe they had limited or no control over an outcome, then Rotter and Mulry’s
(1965) second construct labeled them with an external LOC. To measure these two
constructs, Rotter and Mulry developed a unidimensional instrument called the InternalExternal LOC (I-E LOC) scale. The instrument was widely successful in different
psychology and healthcare fields along with the field of employment. The effect
generalized expectancy theory had on people’s LOC provided a theoretical foundation for
examining thought processes associated with ongoing drug use.
Since 1965, researchers adapted, modified, and translated the generalized I-E
LOC scale for use in 43 countries and with those who speak different languages.
Calicchia (1974) adapted the I-E LOC scale to measure LOC variations based on the use
of narcotics. Keyson and Janda (1972) modified the I-E LOC scale to develop the
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Drinking Related Internal-External (DRIE) LOC scale to measure LOC in alcoholics.
Hall (2001) modified the DRIE instrument by changing the word alcohol to the word
drug. Hall (2001) also changed other words associated with the use of alcohol to words
associated with drug use to develop the DRLOC scale. The DRLOC instrument and all
other LOC instruments developed before and afterward were based on Rotter and
Mulry’s I-E LOC instrument.
Hall (2001) and Ersche et al. (2012) administered the DRLOC instrument with
500 plus participants that resulted in men’s LOC score being external. Hall (2001)
questioned the results from studies with a small number of participants that documented
most of the women produced an external score and studies with a large number of
participants that demonstrated most of the men produced an external score.
The current study adds to Hall’s research by examining gender, primary drug use,
and their influence on DRLOC scores. The role of LOC and thought processes associated
with drug use among men and women provided a conceptual foundation for the current
study. Generalized expectancy theory provided a theoretical foundation for the current
study and helped to understand why drug use continues.
Problem Statement
The UNODC (2015b) suggested opiates and opioids are the main culprits for most
drug related deaths globally. In the United States, there was an increase in heroin usage
from 15% in 2004 to 22% in 2014 and opiate abuse from 3% in 2004 to 8% in 2014
(SAMHSA, 2016c). Methamphetamine abuse increased from 6% in 2004 to 9% in 2014
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(SAMHSA, 2016c). Methamphetamine is the most commonly used illegal drug in
California compared to heroin as a primary drug (CDADP, 2013). In California, there
were 48,345 admissions into treatment for Methamphetamine and amphetamine abuse.
Cocaine and crack cocaine accounted for 7375 admissions. Treatment for heroin abuse
resulted in 38,785 admissions, while opiate abuse had 8,468 admissions (SAMHSA,
2016d).
The focus of this study was to examine the effect gender and primary drug had on
DRLOC. I was unable to locate recent research focused on LOC and narcotics, LOC and
stimulants, or LOC with narcotic and stimulants.
There were limited numbers of assessment tools used for measuring drug-related
disorders and LOC. The original I-E LOC scale measured individuals’ belief in whether
they could control their consumption of alcohol and did not focus on drug abuse (Rotter
& Mulry, 1965). Calicchia (1974) used the I-E LOC scale to measure LOC and heroin
usage. Hall (2001) developed the DRLOC scale to focus specifically on drug abuse
among people in treatment programs. Ersche et al. (2012) studied the reliability of the
DRLOC scale and reported the DRLOC scale to be an effective assessment tool for
measuring LOC in people with substance use disorders. Their study measured LOC in a
large sample of 592 participants with a history of alcohol and drug abuse. Past studies
that used a generalized LOC instrument provided small sample sizes of less than 100
participants and often less than 50 participants (Hall, 2001). I used Hall’s data generated
from 553 participants to identify a subset of 402 participants; 117 identified narcotics as
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their primary drug and 285 identified stimulants (cocaine, crack, amphetamine, or
methamphetamine) as their primary drug. Once I identified the target sample, I examined
their DRLOC scores to determine group mean differences by primary drug (narcotics vs.
stimulants) and gender (male vs. female).
Purpose of the Study
The current study is a pre-experimental, quantitative study utilizing secondary
data from a study conducted by Hall (2001) titled, Feelings About Drug Use, DrugRelated Locus of Control, which, itself, was a follow-up to the University California Los
Angeles’ (UCLAs) Integrated Substance Abuse Programs’ study titled, Drug Treatment
Process and Drug Treatment Counselor Practices and Effectiveness study. The purpose of
conducting this secondary analysis was to reexamine data regarding individuals who
received treatment for their substance use disorders. Specifically, I examined the main
factorial effects of primary drug (narcotic vs. stimulant), gender (men vs. women), and
their interaction on DRLOC. In Chapter 2, I provide an in-depth discussion of the
literature about the DRLOC instrument and its relationship to narcotic and stimulant
disorders.
Research Questions and Hypotheses
The dependent variable is DRLOC, in which a low score indicated an internal
LOC and a high score indicated an external LOC. Chapter 3 includes an in-depth
description of the instrument. The independent variables are primary drug (narcotic or
stimulant) and gender (male or female). Of primary interest was the effect of the primary
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drug on DRLOC score, but because Hall (2001) found males had statistically significant
higher DRLOC score than females, it was important to control for gender and examine
any interaction effect between gender and primary drug.
Coffey, Schumacher, Baschnagel, Hawk, and Holloman (2011) reported
addictions contribute to maladaptive behaviors based on the lack of impulse control. The
Drug Enforcement Administration (DEA, 2013), found a relationship between both
narcotic and stimulant disorders and compulsive and impulsive behaviors. Bornovalova,
Daughters, Hernandez, Richards, and Lejuez (2005) found people who used stimulants
had a higher propensity for risky behavior and impulsivity than people who abused
heroin. Furthermore, McAnena, Craissati, and Southgate (2016) suggested there is a high
correlation between maladaptive behaviors, impulsivity, and external LOC. Although
these findings suggested patients with substance use disorders who choose stimulants as
their primary drug would produce an external LOC score based on impulsivity and a
perceived lack of control over their maladaptive behaviors. All hypotheses for the
proposed secondary analysis are nondirectional in order to afford an unbiased assessment
of the data. To simplify the hypotheses that follow, the test of a specific effect assumes
statistical control for the other effects.
RQ1: To what extent do DRLOC scores differ by primary drug (narcotic vs.
stimulant), gender (male vs. female), and their interaction?
N01: There is no statistically significant difference (p > .05) in DRLOC scores
between participants whose primary drug was a narcotic versus a stimulant.
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Na1: There is a statistically significant difference (p < .05) in DRLOC scores
between participants whose primary drug was a narcotic versus a stimulant.
N02: There is no statistically significant difference (p > .05) in DRLOC scores
between males and females.
Na2: There is a statistically significant difference (p < .05) in DRLOC scores
between males and females.
N03: There is no statistically significant interaction effect (p > .05) between
primary drug and gender on DRLOC scores.
Na3: There is a statistically significant interaction effect (p < .05) between
primary drug and gender on DRLOC scores.
Theoretical Foundation
Rotter (1966) introduced the generalized expectancy theory as a social learning
theory addressing impulsive reactions supported by cognitive and behavioral responses to
environmental stimuli. Generalized expectancy theory helped to explain the behavior of
patients diagnosed with substance use disorders and their inability to control addictive
behaviors associated with ongoing drug use. Rotter explained that the nature of impulse
response is related to a current situation that is similar to prior experiences. Patients
generalize the outcomes related to past drug-related experiences and used them to
reinforce their behavior with similar drug-related experiences in the future, thereby
establishing preconceived expectations. More details about generalized expectancy
theory are provided in Chapter 2.
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Addictive disorders involve behaviors related to impulsive and compulsive
actions, including the inability to self-regulate or control behaviors (Sheffer et al., 2012;
Webb, Sniehotta, & Michie, 2010). Due to the construct lack of control as related to
substance use disorders, Rotter’s generalized expectancy theory provided a
comprehensive explanation and the theoretical basis for understanding what drives
ongoing addictive behaviors.
Conceptual Framework
Cognitive awareness of control is relevant to the assessment of ongoing substance
use. Examining LOC was appropriate for measuring patients’ expectations regarding how
much control they had or thought they had over their drug use based on prior experiences
with drug-related activities (Sheffer et al., 2012; Webb et al., 2010). Internal LOC is
defined as people’s ability to understand their role in a given situation and acceptance of
the level of control they had in the outcome (Rotter & Mulry, 1965). People believing
they had little control over a given outcome due to luck, faith, or another factor outside
their control met the definition of external LOC (Rotter & Mulry, 1965).
By applying the constructs of LOC, researchers could identify a person who
believed he or she had a certain amount of control over their drug use compared to a
person who believed there were other factors in the environment causing him or her to
continue drug use. Examining LOC, coupled with generalized expectancy theory as
applied to addiction, could help to identify patients’ expectations about what might occur
due to prior positive or negative experiences with similar situations or events.
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Generalized expectancy theory and LOC could help practitioners determine a reason for
ongoing drug use or sustained abstinence.
The use of the DRLOC scale at the beginning, during, and at the end of treatment
could help measure shifts in thought processes, behaviors, and quality of life (Pasareanu,
Opsal, Vederhus, Kristensen, & Clausen, 2015). Men and women who used narcotics or
stimulants as their primary drug could benefit from learning their DRLOC score.
Nature of the Study
The current study is a preexperimental static group comparison. The DRLOC
instrument measures thought processes associated with drug use. I extracted from the 553
participants in Hall’s study a subset of 402 participants to conduct secondary analysis of
data from participants who completed the DRLOC instrument and identified a narcotic or
stimulant as their primary drug. The purpose for identifying narcotics and stimulants was
they were the most abused drugs in the United States (SAMHSA, 2016c), and has been
identified as the most abused drugs upon admission into treatment programs in California
(CDADP, 2013; SAMHSA, 2016d).
I obtained permission from Hall and representatives at the UCLAs Integrated
Substance Abuse Programs to use the data generated from the DRLOC study (see
Appendix A). For this study, the dependent variable was DRLOC score, in which a score
of one indicated an internal LOC and a score of two indicated an external LOC. The
independent variables were primary drug (narcotic or stimulant) and gender (male or
female). The primary analysis was a 2x2 full factorial ANOVA. To describe the sample,
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age, race, socioeconomic status, and education level were reported. If any of these
demographic variables are found to be related to the DRLOC score, they were included
as a covariate in the primary analysis. Operationalization of all variables is detailed in
Chapter 3.
Definition of Terms
The following clarifies and defines the words used in the study.
Addiction: Addiction is a brain disorder or neurological disease caused by
molecular changes in the brain when foreign chemicals are introduced into the body’s
system (APA, 2013).
Addictive Behaviors: Addictive behaviors consists of impulsive and compulsive
actions and reactions associated with drug use due to peoples’ inability to self-regulate or
control their impulses when faced with internal and external stimuli (Rotter, 1966;
Sheffer et al., 2012; Webb et al., 2010). These biopsychosocial patterns of addictive
behaviors include ongoing substance use or impulsive and compulsive patterns of
maladaptive behaviors despite disruptions to the family system, social relationships,
educational achievement, and employment obligation.
Dopaminergic System, Serotonergic System, Mesocorticolimbic System, and
Endogenous Opioid Systems: These systems are different areas of the brain that produce
neurotransmitters to communicate from one region of the brain to another. These systems
are part of the reward circuitry responsible for reinforcing and maintaining addictive
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behaviors (Karim & Chaudhri, 2012; Leeman & Potenza, 2013; Neto & True, 2011;
Niehaus et al., 2009).
Generalized Expectancy Theory: A person develops expectations for a present
situation by comparing similar events or outcomes that occurred in the past. It is during
past experiences that patterns of behaviors and anticipation determine how one would
respond to similar experience in the future (Rotter, 1966).
Locus of Control: Locus of control is a person’s ability to believe he or she had
some control or no control over the outcome of a situation or event (Rotter & Mulry,
1965).
Narcotics: Narcotics consists of opium, morphine, hydromorphone, codeine,
oxycodone, hydrocodone, tramadol, buprenorphine, methadone, meperidine, pentazocine,
propoxyphene, and any other drug with morphine-like effects (SAMHSA, 2016c).
Primary Drug: The primary drug is a person’s preference for a particular drug
(SAMHSA, 2016c).
Stimulants: Stimulants consists of amphetamines, Methamphetamines, cocaine,
and crack cocaine (SAMHSA, 2016c).
Substance Use Disorder: Substance use disorders are neurological diseases
defined as physiological and psychological dependence on foreign chemicals introduced
into the body (Buckland, 2008; Caan, 2012; Carlson & Larkin, 2009; Congdon & Canli,
2008; Davidson et al., 2008; Shor & Levit, 2012). The dependence on these foreign
chemicals interferes with a person’s ability to function socially, causing significant
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biopsychosocial impairment and maladaptive behaviors that negatively impact the
person’s quality of life (Buckland, 2008; Caan, 2012; Carlson & Larkin, 2009; Congdon
& Canli, 2008; Davidson et al., 2008; Shor & Levit, 2012).
Assumptions
I used secondary data generated from UCLAs Integrated Substance Abuse
Programs that conducted two studies with the same population. The original study was
the Drug Treatment Process and Drug Treatment Counselor Practices and Effectiveness
(Hall, 2001). From this population, a second study was conducted by Hall (2001), the
Feelings About Drug Use, Drug Related Locus of Control (DRLOC). UCLAs Integrated
Substance Abuse Programs recruited participants from 19 treatment programs within Los
Angeles country representing five treatment modalities: inpatient programs, outpatient
programs, residential programs, day programs, and methadone maintenance treatment
programs (Hall, 2001).
Davis, Doherty, and Moser (2014) indicated the need to present oneself in a
favorable way to make a positive impression or to exaggerate responses to feel socially
acceptable are all concerns when administering self-report instruments like the DRLOC
scale. I assumed all participants in the original UCLAs Integrated Substance Abuse
Programs’ study and Hall’s Feelings About Drug Use, DRLOC study were truthful with
their responses to questions on the DRLOC scale. I also assumed the programs under the
UCLAs Integrated Substance Abuse Programs did not coerce participants to be involved
in one or both studies or made them feel obligated to participate. It is noteworthy, some
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participants from the original UCLAs Integrated Substance Abuse Programs’ study
declined to participate in the Feelings About Drug Use, DRLOC study (Hall, 2001).
Scope and Delimitations
The current study used secondary data generated from the Drug Treatment
Process and Drug Treatment Counselor Practices and Effectiveness study and the
Feelings About Drug Use, DRLOC study conducted by the UCLAs Integrated Substance
Abuse Programs (Hall, 2001). These studies represented a sample of 19 different
programs from five different treatment modalities whose participants were tested for 10
identified abused drugs. The Drug Treatment Process and Drug Treatment Counselor
Practices and Effectiveness study included 666 participants. The Feelings About Drug
Use, DRLOC study included 553 participants. I used data from the Feelings About Drug
Use, DRLOC study to examine DRLOC scores of 553 participants (men and women). I
identify a subset of 402 participants who indicated either a narcotic or stimulant as their
primary drug. My focus was to determine if primary drug used among men versus
women effect the DRLOC score.
Generalized outcomes associated with prior addictive behaviors could influence
the patient’s belief system, which may be directly related to the primary drug. This could
imply a connection between cause and effect. I only seek to explore an association
between the three variables (gender, primary drug, and LOC score) but not whether a
cause and effect relationship exists. Any appearance of a cause and effect association is
coincidental.
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Limitations
Hall’s (2001) Feelings About Drug Use, DRLOC study provided an overview of
the methodology, procedure, and instruments administered during the UCLAs Integrated
Substance Abuse Programs’ study, titled Drug Treatment Process and Drug Treatment
Counselor Practices and Effectiveness. However, detailed procedures on how the
instruments were administered were not provided. I limited my investigation to the
information provided by Hall’s 2001 report on the Feelings About Drug Use, DRLOC
study, which used the original data generated by UCLAs Integrated Substance Abuse
Programs’ study.
Limitations involving participants’ reading and writing abilities were a concern.
SAMHSA (2012) indicated 64.1% of people with an addiction finished high school. I
was not able to locate information indicating the comprehension level of the DRLOC
scale or the I-E LOC scale. Rotter’s I-E LOC study recruited college students. In Hall’s
study, there were no indications whether interviewers read to participants and then
completed the instrument by marking the answers provided, or if each participant
independently completed the surveys and questionnaires provided to them by the
interviewers. Hall’s (2001) report did indicate the education level of those who
participated in the UCLAs Integrated Substance Abuse Programs’ study averaged 12.2
years.
Threats to internal validity were also a major concern. People with addictive
behaviors often demonstrated a lack of responsibility, such as not keeping appointments
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or not following through with completing studies. Hall (2001) documented there were
666 participants in the UCLAs study, of which 565 participated in the DRLOC study and
101 participants declined. Hall’s report also indicated there were participants who did not
complete all 15 items on the DRLOC scale. Hall did not note the reasons why those who
participated in the study did not complete all 15 items. Hall did not document the exact
number of incomplete instruments. Hall did include instruments with at least 12 of 15
items completed in the final analysis.
There might be a potential threat to internal validity as participants are patients in
programs directly affiliated with UCLAs Integrated Substance Abuse Programs. The
phenomenon of patients giving socially appropriate responses compared to honest
responses representative of their addictive behaviors, counseling experience, and thought
processes could affect internal validity. Therefore, potential information bias could have
been present. It is not clear from Hall’s (2001) report if participants of the UCLAs
Integrated Substance Abuse Programs’ study were required to respond due to their
affiliation with the UCLAs Integrated Substance Abuse Programs. However, what is
clear from Hall’s (2001) report is there were participants who declined to participate in
the follow-up study, Feelings About Drug Use, DRLOC.
Extraneous and confounding variables from biopsychosocial triggers in the
environment are other issues of concern regarding threats to internal validity. These
variables could have influenced behaviors and thought processes and thereby effected
responses to questions given in the UCLAs Integrated Substance Abuse Programs’ study
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and Hall’s DRLOC study. An example of an extraneous variable could have been
participants under the influence of drugs while completing the DRLOC instrument.
Significance of the Study
Addiction is a multidimensional disease with complex habitual behaviors (Caan,
2012; Carlson & Larkin, 2009). Researchers determined all types of addictions are
similar in their etiology, functionality, physiological and psychological withdrawal
processes, and neurobiological effects at a cellular level (Gifford & Humphreys, 2007;
Grant et al., 2010; Heidbreder, 2008; Niehaus et al., 2009). Furthermore, addiction
impacts behavior (Gifford & Humphreys, 2007; Heidbreder, 2008; Niehaus et al., 2009)
and stages of recovery (DiClemente, 2003; Norcross et al., 2011). By understanding the
thought processes of people with an addiction clinician could better address addictive
behaviors with appropriate evidenced based interventions.
The focus of this study was threefold: to examine if narcotic or stimulant used
among men and women effect the DRLOC score, to address Hall’s (2001) question
related to gender and external LOC score, and to enhance the body of work that Hall
(2001) and Ersche et al. (2012) presented by determining if there is usefulness in
implementing the DRLOC scale as an individualized instrument to be included in the
treatment process. Implementing the DRLOC instrument at the time of admission, during
treatment, and toward the end of treatment (Pasareanu et al., 2015) could potentially help
measure patient’s progress in treatment through personal awareness and shifts in thought
processes and behaviors, or the lack thereof. The DRLOC scale could provide a
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reasonable understanding of the minimal progress achieved and it could help determine
the appropriate interventions needed that coincide with the patient’s LOC score.
The results of this study could have significant social change implications for the
addiction, medical, and mental health fields due to a potential increase in understanding
the interdependency of I-E LOC and primary drug used by patients receiving treatment
for substance use disorders. This approach supports the need for practitioners and patients
to work together to develop interventions throughout treatment as they address addictive
behaviors. By understanding the LOC score, practitioners and patients alike could
recognize addictive behaviors better and make decisions regarding intervention strategies.
Implementing the DRLOC scale as an integral part of treatment seemed to be a natural
next step in the field of addiction to assess how people view their control, or lack thereof,
over addictive behaviors.
Social Change Implications
When addressing addiction as a social problem, it is important to
understand the disorder as a multifaceted disease that effects not only the individual but
loved ones and the broader society. The social implication of utilizing the DRLOC
instrument in treatment programs and educating patients about their DRLOC score could
help patients become aware of their LOC and gain an understanding of how their ongoing
drug use was connected to how they viewed a situation and prior experiences and what
might have been their triggers. This awareness could help patients recognize and avoid
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places, people, and things that contribute to relapses, thereby helping patients shift from
using drugs toward gaining and maintaining abstinence.
Foon (1986) suggested practitioners administer a LOC instrument as part of
family therapy with each family member. Foon asserted a better understanding of a loved
one’s addictive behaviors and level of control toward drug use exists when each family
member is aware of their own LOC score and how this impacts their interactions with
others. Being aware of one’s LOC score may help family members change their
perception and the stigma associated with addictions (Foon, 1986).
Addiction is seen as a socially pejorative term with stigmatizing connotations,
such as drug addict and dope fiend (Davidson et al., 2008). Social implications from the
general public becoming educated about LOC and one’s personal score could help the
public recognize their thought processes associated with daily responses to events and
situations. This awareness could result in positive shifts in how the public view and treat
people with a substance use disorder (Davidson et al., 2008; Karim & Chaudhri, 2012;
McLachlan & Starkey, 2012).
Sigma that exists in the medical and mental health fields was addressed by
Davidson et al. (2008), as well as Larkin et al. (2006). They suggested encouraging
professionals in the medical and mental health fields to start addressing patients as
individuals who are experiencing an addiction and not to focus exclusively on the
addiction controlling the individual. For example, Davidson et al. (2008) suggested
saying people with an addiction instead of saying heroin addicts as more appropriate
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language. The social implication of using person-first allowed for an understanding of the
disorder as a disease instead of a disorder out of one’s control (Davidson et al., 2008).
Social implications for treatment programs that administer the DRLOC scale
could be beneficial for measuring treatment success. Obtaining the DRLOC score during
the initial admission could help with selecting appropriate treatment interventions at the
beginning of treatment. When administering the DRLOC scale halfway through
treatment, the score could help practitioners and patients better recognize the thought
processes behind addictive behaviors and how to control them. The score could then help
to determine if adjusting interventions during the treatment process is needed. When
administering the DRLOC scale toward the end of services, the score could help to
measure progress or lack thereof and provide an informed discharge plan (Connolly,
1980).
Foon (1986) concur with using an individualized assessment instrument such as
the DRLOC scale as a pre and post-assessment tool to help the practitioner gauge the
thought processes of the patient. By obtaining the patient’s LOC score, practitioners and
other professionals in addiction, medical, and mental health settings could better
understand the psychological dependence that drives ongoing drug use at an
individualized level (Foon 1986). Furthermore, by understanding the thought processes of
patients, practitioners could develop treatment interventions based on where patients are
in their thought processes, either internally or externally (Foon, 1986).
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According to Rotter and Mulry (1965), patients with an internal LOC score would
more likely attend treatment programs regularly, work at strengthening coping skills,
have a willingness to learn more about their addiction and addictive behaviors, would
remember information that helped them in their recovery, and would work harder at
setting and achieving goals. Rotter and Mulry (1965) further explained patients with an
external LOC score would take longer to work on cognitive and behavioral skills as they
learn to accept responsibility for addictive behaviors.
A more progressive practice, according to Foon (1986), is to administer a LOC
instrument for practitioners as well as patients. Utilizing a LOC instrument for both
professionals and patients would help to minimize stigma in treatment settings (Foon,
1986). For example, making practitioners aware of their external LOC would help them
work on shifting their thought processes toward an internal LOC, or matching an internal
thinking professional with an internal thinking patient could increase favorable results
(Ersche et al., 2012).
Social implications for clinicians in multiple human service fields and community
organizations could benefit by knowing the DRLOC score that could then be aligned with
appropriate evidence-based interventions (National Registry of Evidence-based Programs
and Practices, 2016). Implementing these interventions could help shift negative
behaviors toward positive behaviors, thereby reducing the human cost associated with
substance use, medical care, mental health treatment, family services, and legal issues
(Caan, 2012; Kreek et al., 2005). For example, the National Institute on Drug Abuse
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[NIDA] (2014) reported how maintaining a sober life could assist with establishing
stability, thereby potentially decreasing incidents of domestic violence and other criminal
activity, along with increasing productivity in the workplace. Retention in treatment
could positively influence personal health and safety associated with accidents,
unintentional overdoses, and premature deaths (Kreek et al., 2005; NIDA, 2014).
According to Hatgis, Friedmann, and Wiener (2008), college students who used drugs
had lower grades, were less likely to participate in extracurricular activities, sought
mental health services, and were more sexually active than students who did not use
drugs.
In 2014, NIDA published a report indicating family members spent billions of
dollars to have loved ones treated by doctors, teachers, social workers, counselors, and
volunteers who worked in the field of addictions, medical, mental health, and in
community organizations. By finding innovative ways to address substance use disorders
and developing appropriate interventions to treat patients, the United States could
generate a savings of up to 12 times the costs of not providing individualized treatment
(NIDA, 2014). Stanforth, Kostiuk, and Garriott (2016), suggested the implementation of
a LOC scale could help guide appropriate treatment interventions that deter addictive
behaviors and cause positive social change to monetary costs of health care, legal, and
educational institutions.
In conclusion, the results of this study could have positive social change
implications for the patient, family members, the general public, practitioners in
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treatment programs, and clinicians in health care fields. Including the DRLOC scale as
part of a practice of integrating evidence-based treatment with empirical assessments
could help identify internal and external thought processes associated with addictive
behaviors and substance use disorders.
Summary
Addiction is a chronic relapsing disease that could develop into a substance use
disorder that causes significant cognitive, behavioral, and social impairment and
negatively effects a person’s quality of life (SAMHSA, n.d.). These negative effects are
responsible for social stigma related to substance use disorders (Davidson et al., 2008). A
social movement to shift public opinions away from a negative view of addiction toward
a positive view of people with substance use disorders was supported by Davidson et al.
(2008), Karim and Chaudhir (2012), and McLachlan and Starkey (2012).
Over the years, substance use disorders reached an epidemic level (Baird, 2015;
Rollins, 2016; Worley et al., 2015). UNODC (2015a) estimated that globally162 to 324
million people in 2012 used illicit drugs. In the United States, between 2008 and 2012,
23.9 million Americans reported using illegal drugs (Cummins et al., 2009; SAMHSA,
2013a). In 2012, California reported 947,000 people abused illicit drugs, but only
115,000 received treatment. California had the highest number of treatment programs in
the United States during 2011 to 2012 (CDADP, 2013). Methamphetamine was the most
commonly reported drug as the primary drug at the rate of 13% higher than heroin
(CDADP, 2013).
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Caan (2012) and Congdon and Canli (2008) noted the development of addictive
behaviors is complex. Rotter (1966) used generalized expectancy theory to explain the
positive and negative experiences that determined whether people would generalize their
current experience or reinforce them using an internal or external belief system. Rotter
(1966) reported impulsive people would respond according to the outcome they expect to
occur, while others would respond feeling they had no control over the outcome. Rotter
and Mulry (1965) termed this belief system LOC and created the I-E LOC scale to
measure internal and external LOC.
The purpose of conducting a pre-experimental quantitative study was to explore
the effect gender and primary drug use had on DRLOC score. Hall (2001) developed the
DRLOC scale to measure LOC in people with substance use disorders. Chapter 2
provides more details about the potential relationship between LOC as an underlying
force that might be driving addictive behaviors in people with substance use disorders.
Scores from the DRLOC scale of men and women identified as abusing narcotics or
stimulants as their primary drug were the targeted population for this study. In Chapter 3,
I review my methodological choices, as well as procedures I used to collect and analyze
the data.
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Chapter 2: Literature Review
There are many ways to approach treatment of a substance use disorder in the
addiction, medical, and mental health fields. Pasareanu et al. (2015) stressed the
importance of using pre and post assessments as an integral part of measuring treatment
interventions and success. Hall’s DRLOC scale is a useful tool as an integral part of the
treatment process, and as a pre and post assessment instrument for measuring patient’s
cognitive awareness of drug-related behaviors and shifts in thought processes.
The purpose of conducting a preexperimental quantitative study was to explore
the effect gender and primary drug use had on DRLOC scores. My study used data from
the UCLAs Integrated Substance Abuse Programs’ Drug Treatment Process and Drug
Treatment Counselor Practices and Effectiveness and the Feelings About Drug Use, to
measure (LOC) by examining the DRLOC score of participants who identified narcotics
or stimulants as their primary drug. The DRLOC scale is an assessment instrument used
to measure LOC in people diagnosed with a substance use disorder. In this chapter, I
provided an in-depth literature review of various related topics, including an explanation
of the theoretical foundation and conceptual framework that provides a firm basis for the
study. I also included the use of the DRLOC scale as a pre and post assessment tool and
the development of the DRLOC instrument.
Literature Search Strategy
A search using addiction related terms and phrases to conduct a literature review
required the use of Walden University’s library to access the following databases:

31
PsycINFO, PsycARTICLES, Mental Measurements Yearbook, Health and Psychosocial
Instruments, SocINDEX, Google Scholar, and ERIC. Other resources included domestic
and international organizations, such as the APA, NIDA, National Institute of
Neurological Disorders and Stroke, National Registry of Evidence-Based Programs and
Practice, and the UNODC. I downloaded the latest SPSS Version 23 for Windows from
Walden University’s Library to perform statistical analysis of the variables.
The key search words, terms, and authors consisted of the following: Whiteside
and Impulsivity, Cyders and Impulsivity, Lynam and Impulsivity, Rotter and Locus of
control, Lefcourt and locus of control, and Hall and locus of control. The following word
search included addiction, addictive behaviors, behavioral addictions, chemical
dependency, substance abuse, stimulants, cocaine, Methamphetamine, narcotics, heroin,
and methadone. Some key phrases that were searched to provide information about the
topics included stimulant addiction, cocaine addiction, Methamphetamine addiction,
opiate dependence, prescription abuse and addiction, and addiction and theories. Other
word searches and phrases included models of treatment for addictions such as
alternative treatment and methadone, models of treatment for recovery, treatment
programs and theories, interventions for addiction treatment, and evidence-based
practices. Word searches and phrases also included stages of development, dropout rate
and treatment, addiction and retention, addiction and attrition, treatment outcome,
cognitive behavioral therapy, mindfulness, self-help programs, neurological disorders
and substance abuse, substance use and mental disorders, reward and addiction, genetics
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and addiction, addiction and brain, addiction and dopamine, addiction and serotonin,
addiction and opioid receptor, contingency and substance abuse, impulsivity and locus of
control, substance abuse and expectancy, addiction and locus of control, self-control and
addiction, free will and addiction, locus of control and free will, external control and
addictions, internal control and addiction, mental health and addiction, co-occurring
disorders and addiction, social change and addiction, coping skills and addictions,
recovery and addiction, men and women and drug use, men and women and substance
abuse, gender and substance use disorders, gender and substance abuse, gender and
drugs, gender and mental health, gender and medical, gender and physical health,
gender, substance abuse, and mental health, and gender, substance abuse, and medical.
The scope of the literature search covered the etiology of addiction, addictive behaviors,
and treatment for substance use disorders. I also reviewed theories and concepts related to
locus of control constructs and generalized expectancy theory and the influence that
generalized expectancy theory and locus of control have on men and women with
substance use disorders.
Theoretical Foundation
Generalized expectancy theory is a social learning theory combining aspects of
reinforcement and cognitive theories to explore the complex nature of human behaviors.
The theory provided a basis for comparing cognitive and behavioral responses to
environmental stimuli (Rotter, 1966). Rotter (1966) suggested generalized expectancy
theory determined how much experience people had in their environment with similar
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results, and whether these previous experiences positively or negatively reinforced a
belief system which placed value on an anticipated outcome. The theory provided a
theoretical foundation for examining the constructs of LOC as related to addiction.
Generalized expectancy theory consists of three elements. The first element is
similarity reinforcement and situational reinforcement. Similarity reinforcement happens
when parallel experiences occur which yield the same outcomes (Rotter, 1966). When
referring to a person with substance use disorders, not only is the stimulus (drug of
choice) available as reinforcement, so is the behavioral response (drug seeking). Thus,
the experience of using the drug creates a level of expectancy with each similar
experience of obtaining the primary drug. For example, a person may travel across town
to an area to seek out a drug dealer and buy heroin. In the past, each time the person
performed this behavior, he or she was successful in accomplishing the goal of finding a
dealer, buying the drug, and then using it. One day the person meets a different dealer
selling the drug, or the person might have to visit a different corner to find a dealer.
Regardless of how the person obtain the drug, the experience is likely to be similar
enough to result in the same outcome of obtaining the primary drug, thereby reinforcing
the behavior of seeking out the drug in the future.
Situational reinforcement develops from a set of conditions that vary and require
decision-making or problem-solving each time it happens. With situational
reinforcement, not only does the stimulus work as a reinforcer, but it initiates a
behavioral response (Rotter, 1975). When a person refrains from drug use and accepts
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abstinence as a developing skill, the person will initiate problem-solving when he or she
begins to desire using a primary drug. For example, when unexpectedly confronted with
the opportunity to share heroin with friends, the person would start to process or problem
solve about the consequences of submitting to drug use. The person may consider the
ramifications of using the drug, which could include starting to use regularly. This could
lead to an increase and frequency of drug use over time.
The second element of Rotter’s (1975) generalized expectancy theory is the value
of the reinforcement. For example, a person traveling across town to a specific house to
buy Methamphetamine would expect the drug dealer to be there. Because the dealer had
always been there in the past, the drug dealer’s presence at the house and being able to
buy Methamphetamine to relieve withdrawal symptoms holds a greater value to the
person than not traveling across town to buy Methamphetamine, and thus, suffering
withdrawal symptoms. Each time the person relieve symptoms of withdrawal,
Methamphetamine becomes more valuable or more rewarding than not seeking it. The
reward serves to reinforce the continued drug-seeking behavior (Rotter, 1975; Skinner,
1976; Watson, 1970).
The final element of Rotter’s (1966) generalized expectancy theory is the
psychological situation that has an impact on expectancies and reinforcement values. In
other words, psychologically, a person’s LOC intervenes and influences his or her belief
in the ability to control outcomes. Given the elements of generalized expectancy theory,
one could predict that during treatment patients with addictive behaviors would start to
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refrain from drug use by avoiding triggers once they are able to recognize the role of
generalized expectancy and LOC.
Review of the Literature
In the United States, the identifiable label for a person who experiences chronic
relapses is an addict, implying addiction is the primary focus and the individual is
secondary (Davidson et al., 2008). What identifies a person as being an addict, or a
person with an addiction, is compulsive drug-seeking and impulsive drug-related
behaviors and ongoing drug use despite negative biopsychosocial consequence (Niehaus
et al., 2009). Schmitz (2005) found the use of the word addiction in the public domain
describes a person’s overuse or misuse of some item or food, or an obsession with a
person or a thing, thereby devaluing the scientific definition of addiction. Schmitz (2005)
further indicated that professionals in the field used the term addiction to address
substance abuse and substance dependence as presented in the Diagnostic and Statistical
Manual of Mental Disorders IV, Text Revision (APA, 2000). However, this did not
address the growing understanding of the role neuro-circuitry had in the development of
addictions. Therefore, to avoid the misuse of the term addiction by non-professionals in
the public domain, and to assure that professionals across disciplines shared the same
understanding of what is an addiction, the Diagnostic and Statistical Manual of Mental
Disorders IV, Text Revision, did not include a category titled addiction (APA, 2000;
Schmitz, 2005).
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In presenting a universal definition to guide all professionals, the Diagnostic and
Statistical Manual of Mental Disorders IV, Text Revision, provided a more specific
definition that identified addiction as being a dependence on, the abuse of, and
withdrawal from a foreign chemical not naturally produced in the body (APA, 2000;
Schmitz, 2005). To establish global consistency about what is an addiction, in 1969, the
World Health Organization discontinued the use of the word addiction and replaced it
with the term drug dependence to capture the physiological and psychological state of
dependence developed from the abuse of substances (Lubman, Yucel, & Pantelis, 2004).
Additionally, in 2011, the American Society of Addiction Medicine presented a
definition of addiction reinforcing it as being a brain disease based on the body of
research focused on neurobiological aspects (Cann, 2012).
Researchers agreed addiction is more than just the use of a substance; they
defined it as a pattern of maladaptive behaviors (Grant et al., 2010). It is now widely
accepted that there are two categories of addictions: Chemical addictions relate to foreign
substances introduced into the body causing neurological changes at a molecular level
(Buckland, 2008; Caan, 2012; Shor & Levit, 2012), and the process of behavioral
addictions that are developed from patterns of impulsive and compulsive behaviors
(Grant et al., 2010; Karim & Chaudhri, 2012). Both types of addictions share commonly
identified biopsychosocial and behavioral features in the areas of development,
maintenance, treatment, and recovery (Grant et al., 2010; Leeman & Potenza, 2013;
McLachlan & Starkey, 2012).
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The Diagnostic and Statistical Manual of Mental Disorders 5 (APA, 2013)
reflected the acceptance of behavioral addictions as a serious disorder and added it as a
category, Non-Substance Related Disorders, along with Substance-Related Disorders, for
chemical addictions. An example of a behavioral addiction is compulsive shopping. A
report by Karim and Chaudhri (2012) examined compulsive shopping among men and
women. The results revealed no significant difference in behaviors with men at 5.5% and
women at 6.0% and implied the disparity between gender and behavioral addictions
might be small.
The definition of addiction provided in the Diagnostic and Statistical Manual of
Mental Disorders 5 is, “a foreign chemical being introduced into the body causing acute
or chronic neurobiological changes that develop into neurological dependence,
physiological reactions from the exposure of foreign chemicals introduced into the
body’s system, chronic relapses resulting from attempts to stop using foreign chemical,
psychological symptoms affecting shifts in thought processes, and behavioral problems
that negatively impacts the person’s quality of life” (APA, 2013, p.585). These changes
in the body are responsible for addictive behaviors, which include patterns of obsessive
drug seeking, continued impulsive drug use, and repeated relapses (Bao et al., 2009). A
level of dysfunction occurs when people lose control over their ability to act and think
rationally regardless of consequences to their health, family and social interactions, and
productivity with educational and vocational endeavors (Bao et al., 2009; Gifford &
Humphreys, 2007; Grant et al., 2010). There were 25 million people in the United States
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who used a chemical substance and were susceptible to developing a substance use
disorder (Baird, 2015).
Researchers in the field of addiction recommended using the scientific approach
to address substance use disorders by focusing on behavioral issues influenced by
compulsive patterns of behaviors (Gifford & Humphreys, 2007; Karim & Chaudhri,
2012; Norcross et al., 2011) while others examined environmental and genetic factors
(Kreek et al., 2005; Lubman et al., 2004). Separately, other researchers embraced a
neurobiological model to explain addiction (Erickson & White, 2009; Leeman &
Potenza, 2013).
Despite advancements in the field of addiction, the stigma associated with
addiction carries a negative social label. This social attitude creates barriers for many
who suffer from substance use disorders that hinder them from seeking formal or
informal treatment (Kulesza et al., 2016). Gender discrimination associated with
addiction also holds a stigma, but racism, sexism, and other status characteristics that
historically marginalized people also contribute to barriers when treating people with a
substance use disorder (Kulesza et al., 2016).
The United States tend to see substance use disorders as the result of illegal drug
use, but not all substance use disorders start from illegal drug use. Legal drugs, such as
alcohol, nicotine, prescription narcotics, and prescription stimulants could develop into a
dependence resulting in addictive behaviors, and then addictive disorders (Davidson et
al., 2008). Davidson et al. (2008) discussed how the stigma surrounding addiction is an
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image of shady characters with no impulse control who steal from family and friends, use
dirty needles, and hide in darkness. Davidson et al. also included homeless people who
cannot not seem to function properly in society. Rarely does the stigma related to
addiction take into account certain segments of society, which do not fit into the category
of an addict, such as people living in high socioeconomic areas or those who hold
positions of authority and respect in organizations and institutions (Davidson et al.,
2008).
For example, the younger population might develop an addiction to substances
stemming from peer pressure (NIDA, 2014). This population includes middle school,
high school, and college students attending weekly parties consuming alcohol, narcotic
and stimulant pills (NIDA, 2014). Davidson et al. (2008) suggested not only are younger
people susceptible to potential dependence and addiction but also the elderly, relatives, or
people we trust, such as police officers, nurses, and teachers, even grandparents. Their
struggles begin when they develope a dependence on prescription narcotics in the
aftermath of recovering from a serious surgery. As the population in the United States
ages, we will face an increase of substance use disorders among patients 60 years and
older with limited treatment programs equipped to address their concerns (Davidson et
al., 2008); approximately 5.4% of elderly patients used illegal drugs (Morgen, DenisonVesel, Kobylarz, &Voelkner, 2015). SAMHSA (2016c) reported the oldest person in
treatment for narcotic abuse was 68.8 years old and the oldest person in treatment for
stimulant abuse was 78.1 years old. Given the right conditions and circumstances, we are
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all susceptible to developing a dependence on prescription medication or a legal
substance along with addictive behaviors associated with the need to alleviate pain or
discomfort (Davidson et al., 2008).
The Centers for Disease Control and Prevention (2016) conducted a longitudinal
study from 2000 to 2014, that demonstrated the prevalence of opiate prescriptions abuse
in the United States. According to the report, opiates, such as oxycodone, morphine,
fentanyl, and other narcotic-based medications, were highly addictive and misused or
diverted; meaning the patient is not taking the medication as prescribed or is giving away
or selling the medication to other people. The misused or diversion of prescription
medications caused 500,000 deaths or 78 fatalities each day due to opiate overdose.
Furthermore, SAMHSA (2016a) indicated 50.5% of opiate abusers got pills from family
and friends, and 22.1% got their pills directly from their physician.
The Center for Behavioral Health Statistics and Quality (2015) reported 1.6
million people in the United States abused prescription stimulants, of which 569,000,
reported using homemade Methamphetamine. SAMHSA’s (2016c) 10-year study of
1,614,358 admissions into treatment programs found only 6% were for
Methamphetamine and amphetamine in 2004. However, by 2014, admissions for
Methamphetamine and amphetamine as a primary drug increased to 9%. SAMHSA
(2016c) reported 54% of admissions for Methamphetamine and amphetamine in 2014
were males with an average age of 33 years old, 67% were White, 18% were Hispanic,
and 4% were Black. Additionally, SAMHSA (2016c) reported that 61% preferred to

41
smoke Methamphetamine and amphetamine, and 26% preferred injections as their
primary route, while 8% preferred inhalation.
Some people used legal or illegal drugs once or occasionally and then never used
them again. There are also those who used legal or illegal drugs repeatedly and risked
becoming physiologically and psychologically dependent (Kreek et al., 2005; Lubman et
al., 2004). Nielsen et al. (2008) attributed this difference to some people having a genetic
predisposition; two-thirds of the people who used opiates do not experience signs of
addiction.
The stigma of seeing patients as addicts and not associating their addictions with a
neurological disease resulted in the need for Davidson et al. (2008) to advocate for social
change. This change started with the addiction industry and the healthcare field.
Davidson et al. (2008), as well as other researchers, such as Larkin et al. (2006),
encouraged individuals, organizations, and the healthcare field to demonstrate a positive
shift in the words they chose to use and the way they treat patients with addictions. They
encouraged practitioners in the helping professions to become more person-centered.
Person-centered is treating people as individuals, thereby providing individualized
treatment plans and not generic interventions (Larkin et al., 2006).
Incorporating the person-centered approach across mental health and addiction
settings could help diminish the stigma associated with substance use disorders, thereby
allowing more people to accept their disorder and then seek treatment without feeling
ostracized. Nonetheless, regardless of how professionals define the word addiction, and
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the different approaches to treating the disorder, the stigma associated with addiction
continued to permeate the United States as the number of people who reported abusing
drugs outnumbered the reported number of patients that entered treatment (CDADP,
2013; SAMHSA, 2013a; UNODC, 2015a). For example, Baird (2015) documented there
were 25 million Americans identified with an addiction, but only 1.6 million received
treatment for a substance use disorder (SAMHSA, 2016c).
Gifford and Humphreys (2005) and Heidbreder (2008) offered reasons for
people's continued chemical or behavioral addiction. They suggested the desire to repeat
the initial euphoric experience initiated a reinforcing response. When exposed to the
chemical, activity, or object a second time, people experienced sensations of satisfaction
but not at the level of the initial introduction. The need to experience the initial level of
euphoria developed into patterns of maladaptive behaviors associated with seeking out
and repeating the use of the chemical, activity, or object.
Gifford and Humphreys (2007) reported patients could experience a chemical
addiction while also struggling with a behavioral addiction. For example, patients could
experience addiction to opiates while also struggling with gambling and compulsive
shopping. If the primary addictive disorder remains untreated, it could become difficult to
treat other identified addictive disorders, therefore, treating various addictive behaviors
requires assessing the target of what drives the patterns of maladaptive behaviors in
individuals (Gifford & Humphreys, 2007). These assessments must also identify the
relationship between the function of the addictive behaviors and the environment
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(Gifford & Humphreys, 2007). The DRLOC scale is an instrument that aids in measuring
thought processes leading to maladaptive addictive behaviors and could potentially serve
as a tool for pre and post assessment.
An extensive review of the literature revealed studies examining impulsiveness
and a person’s LOC, as it relates to substance use disorders. Altamirano et al. (2011)
examined the relationship between impulsivity, LOC, and chemical addictions. They
researched the use of the drug naltrexone that doctors prescribed to treat alcoholism. The
researchers revealed participants with an internal LOC demonstrated an increase in
impulsivity while taking naltrexone. Participants identified with external LOC had an
opposite effect and demonstrated less impulsivity while on the medication.
Sheffer et al. (2012) examined nicotine dependence and LOC in a population with
low socioeconomic status. The researchers revealed the population tended to have an
external LOC and greater stress. The researchers concluded the targeted participants
would most likely not achieve abstinence from tobacco after completing a treatment
program. Furthermore, their study demonstrated external LOC reinforced impulsive traits
that hindered abstinence. (Sheffer et al., 2012).
Bornovalova et al. (2005) examined the effects of both narcotic and stimulant use
on behavior. They found chronic stimulant use could cause neurological damage which
impairs judgment and decision making.
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The Etiology of Substance Use Disorders
Understanding the mechanisms responsible for substance use disorders is
important, as every individual enters treatment with their own complex biopsychosocial
history (Gifford & Humphreys, 2007). This history could include a combination of
genetic factors, environmental influences, and neurological changes in cognitive
processes (Gifford & Humphreys, 2007; Grant et al., 2010; Nielsen et al., 2008).
Different researchers have varying perspectives of what causes substance use disorders
(Heidbreder, 2008). For example, Buckland (2008) theorized either genetic, environment,
biology or personal experiences could make one person more susceptible than another.
What is agreed upon is that foreign chemicals effect the brain and body’s ability to
function efficiently, causing neurological, psychological, and physiological dependence
(NIDA, 2014). Some people develop an addiction that causes biopsychosocial disruptions
in their daily life that decreases their quality of life, while others do not (Erickson &
White, 2009). Attempts at achieving stability without continued abuse of the chemical is
often challenging and involves chronic relapses (NIDA, 2014).
Genetics
Susceptibility to foreign chemicals may have very little to do with learned
behavior and more to do with genetics (Levran et al., 2009). Genetics might play a
significant role in one’s susceptibility to dependence (Nielsen et al., 2008). All people
have genetic variances associated with classes of drugs such as opiates or specific genetic
heritability such as alcoholism (Kreek et al., 2005). For example, genetic researchers
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discovered a propensity for alcoholism is due to receptor genes that correlate with
dependent behaviors (Buckland, 2008). Levran et al. (2009) examined the genetic
influence of heroin. They agreed heroin dependence, much like alcoholism, has a genetic
component which contributes to patients being susceptible to ongoing drug use and
chronic relapses.
Nielsen et al. (2008) suggested genetics might also provide a level of control
when resisting addictive behaviors. Two-thirds of patients who started using opiates do
not become addicted because of their genetic predispositions. However, approximately
one-third of those who tried using opiates developed an immediate psychological and
physiological dependence (Levran et al., 2009; Nielsen et al., 2008; Vohs & Baumeister,
2009). Their usage lead to the development of addictive behaviors and resulted in a
diagnosis of substance use disorders (Levran et al., 2009; Nielsen et al., 2008; Vohs &
Baumeister, 2009).
While gender and exposure to stress factors into a person’s drug use, adding
sensitization, vulnerability and genetic influences could increase the risk for addiction
(Berridge & Robinson, 2016). Vohs and Baumeister (2009) concur and reported there is a
need to factor in people’s genetic makeup and neurological vulnerabilities, which could
play a role in addiction and the propensity for multiple addictions. Berridge and Robinson
(2016) reported, research in this area demonstrated the brain’s sensitivity to drugs effects
neurons like the dopamine, glutamate and mesolimbic neurons, and drug abuse effect
neurotransmitters. For example, the shape of the mesolimbic neuron and the number of
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dendritic spines could be altered. This causes a hyperreactive response to environmental
triggers associated with a foreign chemical, reinforcing a person’s need to obtain the
primary drug more salient. Berridge and Robinson (2016) also reported individual
vulnerabilities, such as genetics, gender, sex hormones, and major stressors are factors
contributing to ongoing drug use for some people. A combination of these factors places
a person at a higher risk for sensitization and potential substance use disorder.
Environmental Influences
The chronological sequence of the development of an addictive disorder begins
with reinforcement of internal or external triggers (Gifford and Humphreys, 2005). As the
person takes actions, such as seeking out and using drugs, the continued use of foreign
chemicals turns into abuse and loss of control (Gifford & Humphreys 2005). When loss
of control becomes apparent, it is due to the reinforcement of an acute neurological
response to the foreign chemical causing euphoria (Gifford & Humphreys 2005).
Heidbreder (2008) suggested this positive reward of euphoria initiates further drugseeking behavior and impulsivity.
Kreek et al. (2005) thought the greatest risk factors for developing an addiction
would surface during adolescence and young adulthood. In the United States, there was
an increase in illegal drug use of 1.7% from 2008 to 2011 among young adults
(Cabriales, Cooper, & Taylor, 2013). Young adults who make up 13.2% of the population
also represented the highest percentage, 32%, of illegal prescription use (Cabriales et al.,
2013). Carlson and Larkin (2009) discussed how addiction occurs because of young
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peoples’ inability to cognitively manage or behaviorally adjust to internal or external
events that tax their coping ability. They further suggested addiction might affect people
of all ages when stress is the catalyst (Carlson & Larkin, 2009). Cyders et al. (2007) and
Whiteside and Lynam (2001) believed understanding the genesis of addiction begins with
understanding the personality traits of an individual. However, they do not know the
exact way personality contribute to developing addictions.
Neurobiology
The accumulated body of research indicated substance use disorders are the result
of neurobiological reactions at a cellular level where molecules create structural changes
and shifts in behavior (Heidbreder & Newman, 2010). Using a foreign chemical presents
the potential for altering the brain’s executive functioning, thereby affecting people’s
ability to control decision-making along with short and long-term memory (Heidbreder &
Newman, 2010; NIDA, 2014).
Researchers further explained that tolerance of a foreign chemical is the body’s
way of seeking the initial effect experienced upon introduction of the chemical
(Heidbreder & Newman, 2010). As time passes, the person needs more of the chemical to
reach a desired euphoric state (Heidbreder & Newman, 2010). In other words, reaching
tolerance required increasing the dose to maintain initial effects of the drug (Scimeca,
Savage, Portenoy, & Lowinson, 2000). Neurological dependence is the result of the body
building up a tolerance for a foreign chemical causing withdrawal syndromes with
sudden cessation (Heidbreder & Newman, 2010).
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Addiction is a complex neurological disease. Neural circuits in the brain send out
different types of neurotransmitters that move from one area of the brain to others
reinforcing addictive behaviors (Karim & Chaudhri, 2012). The dopaminergic system
releases different neurons to the serotonergic, mesocorticolimbic, and endogenous opioid
systems (Karim & Chaudhri, 2012; Leeman & Potenza, 2013; Neto & True, 2011;
Niehaus et al., 2009). The main region of the brain responsible for reinforcing addictive
behaviors is the mesolimbic reward system where primitive drives make people
instinctively seek out food, shelter, and sex (Karim & Chaudhri, 2012). All drugs activate
reward systems, but the mesocorticolimbic system is most important to understanding the
reward circuit and addictive drives. It consists of two areas, the mesolimbic and the
mesocortical pathways (Leeman & Potenza, 2013).
The ventral tegmental transmits the dopamine through the nucleus accumbens,
also known as the mesolimbic pathway, and from the ventral tegmental to the prefrontal
cortex, also known as the mesocortical pathway (Leeman & Potenza, 2013; Niehaus et
al., 2009). Karim and Chaudhri (2012) included the endogenous opioid systems with the
dopaminergic system as most influential to reinforcing additive behaviors through reward
activation. Dopaminergic neurons activate reward circuitry in the brain located in the
amygdala, the prefrontal cortex, the hippocampus, and frontal cortex regions (Leeman &
Potenza, 2013; Neto & True, 2011).
Serotonin is a monoamine neurotransmitter, which travels through serotonergic
pathways located in the ventral tegmental area of the brain the prefrontal cortex and the

49
amygdala (Neto & True, 2011; Niehaus et al., 2009). The serotonergic system releases
low levels of serotonin increasing levels of risky behaviors (Neto & True, 2011). In
contrast, the dopaminergic system releases elevated levels of dopamine, creating rewardseeking behavior (Neto & True, 2011). Leeman (2013) reported either high or low level
of dopamine could lead to impulsive, risk-taking behaviors. Impulsivity, a characteristic
of addictive disorders, render people helpless in the face of impetuous behaviors that the
brain’s reward system reinforces (Whiteside & Lynam, 2001). The reinforcement causes
an uncontrollable urge or strong motivation to seek out drugs, thereby causing a lack of
control over addictive behaviors associated with substance use disorders (Neto & True,
2011).
Heidbreder (2008) suggested dopamine was responsible for emotions and
people’s cognitive ability to function. The researcher further asserted that dopamine was
the culprit responsible for ongoing activities associated with substance use disorders
(Heidbreder, 2008). The nucleus accumbens produce two main dopamine sub-type
neurons: dopamine D1 and dopamine D2 (Levran et al., 2009). Dopamine travels to the
ventral tegmental area, then onward to the nucleus accumbens, the olfactory tubercle, and
then the ventral striatum (Levran et al., 2009). The mesocortical and mesolimbic tract is
the second passage from the ventral tegmental to the cortex (Littrell, 2010; Nielsen et al.,
2008). These tracks work together in releasing dopamine throughout the brain,
reinforcing positive and negative response to initiating addictive behaviors associated
with substance use disorders (Littrell, 2010; Nielsen et al., 2008). Scientists have not
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fully understood the expression of neuron receptors of dopamine D1 and dopamine D2,
or how the nucleus accumbens mediates their interaction to reduce sensations of reward
(Levran et al., 2009).
Researchers focused on specific areas of the brain that help the addiction industry
understand the development of substance use disorders. For example, Schmitz (2005)
indicated the nucleus accumbens are where three types of opioid receptors are located
and are responsible for hedonic responses, Mu, Delta, and Kappa receptors. These
receptors react to signals delivered from the central nervous system where three opioid
systems called the Beta-endorphin, the enkephalins, and the dynorphins produce hedonic
responses that initiate rewards or cravings (Levran et al., 2009; Schmitz, 2005).
There are other sections of the brain influenced by emotional stimuli. Nielsen et
al. (2008) suggested the amygdala draws attention to emotional stimuli, such as stress or
grief, thereby stimulating sensory input. This activation influences the orbitofrontal
cortex, which modulates emotions. Nielsen et al. (2008) further explained both amygdala
and the orbitofrontal cortex appear to influence each other through the stimulation of
neurons. The orbitofrontal cortex receives information from the amygdala and indirectly
from the amygdala through the anterior cingulate cortex. Nielsen et al. (2008) also
suggested the prefrontal cortex is part of the brain responsible for executive functions,
including self-control. Frontal lobes affect substance use disorders by causing acute
effects to chronic dysfunctions (Nielsen et al., 2008).
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Bornovalova et al. (2005) and Haile, Kosten, and Kosten (2008) discovered the
introduction of stimulants into the reward circuitry dopamine partially blocks antagonists
as they produce euphoria. Researchers determined that stimulants could interfere with
perceptual motor speed and cause neuropsychological inhibition, impair behavior, as well
as neuroanatomical abnormalities affecting concentration, memory loss, and the inability
to learn information. Karim and Chaudhri (2012) suggested both chemical and behavioral
addiction stimuli affect the neurological pathways. They further suggested
overstimulation such as triggers in the environment has the potential of altering the
reward circuitry and could cause repetitive behaviors that are out of one’s control. Karim
and Chaudhri (2012) called repetitive behaviors, addictive behaviors. Addictive
behaviors are maladaptive behaviors responsible for the lack of control over actions and
ability to think rationally regardless of negative consequences (DEA, 2013; Gifford &
Humphreys, 2007; Grant et al., 2010; Sheffer et al., 2012).
As cases of substance use disorders increased, it was important to understand the
underlying neurobiological mechanism and the neuro-adaptation of addictive behaviors
associated with relapses. First, substance use disorders and the accompanied addictive
behaviors influence neurobiological functioning (Buckland, 2008; Gifford & Humphreys,
2007; Grant et al., 2010; Kreek et al., 2005). Second, personality traits play a significant
role in how a person reacts to their internal and external triggers (Cyders et al., 2007;
Whiteside & Lynam, 2001). Finally, operant conditioning and negative reinforcement
create a chronic cycle of repetitive behaviors each time a person experiences a stimulus in
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the environment (Lefcourt, 1966; Rotter, 1975; Schmitz, 2005). Most importantly, Karim
and Chaudhri (2012) concluded, any stimuli which alter the reward circuitry and causes
repetitive behaviors could lead to addictive disorders.
Psychological and Physiological Dependence
Gifford and Humphreys (2007), and Grant et al. (2010) found the most pertinent
indicator of being physically dependent on a foreign chemical is when the absence of the
foreign chemical produces withdrawal symptoms. Withdrawal syndromes manifest as
physiological and psychological reactions that cause discomfort. Physical dependence is
the result of the body physiologically adapting to the introduction of the drug into the
body’s system on a regular basis (Gifford & Humphreys, 2007; Grant et al., 2010). To
alleviate withdrawal, the person progressively needs to use more of the foreign chemical
for symptoms to subside (Gifford & Humphreys, 2007; Grant et al., 2010).
Other signs a chemical dependence has developed are when a person becomes
aware of the length of time in which the use of a drug occurs and the increased need to
use more of the drug (Gifford & Humphreys, 2007; Grant et al., 2010). Gifford and
Humphreys (2007), and Grant et al. (2010), further agreed that additional signs of
neurological dependence and the development of an addiction include the time and
energy consumed in seeking out, finding, using, and recovering from the use of the
chemical.
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Gender and Substance Use Disorder
In the field of addiction, conflicting ideology of treating all men and women as
equal, compared to addressing gender-specific needs, was a dilemma for some treatment
programs because men and women are different biopsychosocially (Lev-Ran, Le Strat,
Imtiaz, Rehm, & Le Foll, 2013; Samuelsson, 2015). Researchers suggested there are
gender differences when examining alcohol, prescription drug, and illegal drug abusers
(Shannon, Jackson, Perkins, & Neal, 2014). This was consistent when examining patterns
of drug use, dependence, prevalence, and specific attributes (Lev-Ran et al., 2013;
Samuelsson, 2015). Green (2006) reported there was no relationship between gender and
admittance to treatment. However, the researcher reported women tend to seek treatment
earlier in their addiction cycle than men (Green, 2006).
Traditionally, when practitioners applied interventions through the lens of
stereotypical masculinity and femininity roles, they placed men and women at equal risk
of missing appropriate treatment (Samuelsson, 2015). They did not take “gender into
account by acknowledging the different experiences, expectations, pressures, inequalities,
and needs of women, men, transgender, and intersex people” (Samuelsson, 2015, p. 189),
as well as cultural factors (Lev-Ran et al., 2013).
The United States population of men was 49% in 2014, while women represented
51%, documenting there were more women than men in the United States (SAMHSA,
2016c). In 2012, there were approximately 23.1 million people in the United States who
needed treatment for substance use disorders, but only 2.5 million sought medical
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attention (Yeom, 2015). In 2011, SAMHSA (2013b) reported 112,978 women were in
opioid treatment programs compared to 161,688 men. This continued to be a statistical
pattern. A longitudinal study conducted by SAMHSA (2016c) revealed more men entered
treatment than women with 68% admission rate in 2004 compared to 66% in 2014. These
statistics indicated a disproportionate number of men sought treatment in contrast to
women (SAMHSA, 2016c).
Women. Across the United States, women represented 541,914 (34%) admissions
out of 1,614,358 admissions into treatment programs. Within this population, the average
age for women who used some form of stimulant was 33 years old for Methamphetamine
and 44 years old for cocaine (SAMHSA, 2016d). The average age for narcotic use was 34
years old for heroin and 33 years old for opiates (SAMHSA, 2016d). SAMHSA (2016d)
reported in 2014 women in California represented 57,781 (36%) admissions into treatment
programs, out of a total of 158,434. Among the admissions in California, 21,084 reported
Methamphetamines were the primary drug, 11,959 reported heroin was the primary drug,
4,074 reported opiates were the primary drug, and 2007 reported crack cocaine or cocaine
were the primary drug (SAMHSA, 2016d).

When women entered treatment, they tended to report more serious
biopsychosocial problems and physiological health issues (Choi, Adams, Morse, &
MacMaster, 2015; Green, 2006; McNeese-Smith et al., 2009; Nelson-Zlupko, Fauffman,
& Dore, 1995). Although both men and women had similar drug use patterns, substance
use disorders had a greater effect on women’s mental health (Green, 2006). Women
presented with severe psychiatric scores and higher rates of mental health disorders
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(Mahmood, Vaughn, Mancini, & Fu, 2013; McNeese-Smith et al., 2009). They also had a
higher rate of physical issues (Mahmood et al., 2013; Shannon et al., 2014). Shannon et
al. (2014) conducted a study examining substance users who were in prison and reported
almost twice the number of women with a substance use disorder had a higher rate of
mental health problems than men with substance use disorder. Women suffered from
major depressive disorder, anxiety disorders (Kang & Deren, 2009; Shannon et al. 2014),
and borderline personality disorder, compared to men who suffered from antisocial
personality disorder (Shannon et al., 2014).
When examining medical utilization among women who used drugs, women met
with more barriers than men. Kang and Deren (2009) reported, compared to men who had
the Human Immunodeficiency Virus and were actively using drugs, women who actively
used drugs and had the Human Immunodeficiency Virus tended to neglect their health by
delaying treatment or experienced difficulty with getting treatment. They also
experienced more symptoms associated with the Human Immunodeficiency Virus and
experienced more side effects from the medication. Women also experienced sexual and
physical abuse more than men, which were factors that kept women from utilizing
healthcare services (Kang & Deren, 2009).
Women used drugs with their significant other (Kang & Deren, 2009), but did not
use drugs as much as men and did not have as many drug related problems (Choi, et al.,
2015; Green, 2006; McNeese-Smith et al., 2009). However, women were more
susceptible to substance addictions and developed substance use disorders faster than
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men (Green, 2006; McNeese-Smith et al., 2009). Women abused specific prescription
drugs such as narcotic analgesics and tranquilizers due to mental health issues and for
managing physical pain (Shannon et al., 2014). Lev-Ran et al. (2013) conducted a study
examining gender differences in prevalence rates of substance use disorders among 11
substances: heroin, cocaine, cannabis, nicotine, alcohol, hallucinogens, inhalants
sedatives, tranquilizers, opioids, and amphetamines. The study indicated women had a
low lifetime prevalence for all the substances mentioned above. However, historical
trends indicated women used, abused, and became dependent on prescription
medications. Lev-Ran et al. (2013) also reported socio-cultural stigmas related to drug
dependence might have been a factor in women limiting or avoiding heavy drug use.
When examining stigma associated with substance abuse, Hatgis et al. (2008)
reported society does not hold women accountable for making poor judgments and
viewed them as “victims of their circumstances” (p. 189). According to these authors, the
women’s degree of responsibility for problems related to alcohol and other drugs
depended on the type of substance they misused. Haseltine (2000) argued the opposite,
stating women who used alcohol and other drugs faced more criticism due to lack of
family support, low socioeconomic status, and mental health disorders.
Historically, women performed poorly in alcohol and other drugs treatment
programs when evaluating the lack of treatment success and low retention rates (NelsonZlupko et al., 1995). Prior treatment for women correlated with them having a mental
health disorder, providers not referring them to treatment, and fewer voluntary
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admissions (Haseltine, 2000). Typically, treatment programs for women centered on
gender norms based on society’s definition of femininity and biases that women need
more help with medical and mental health assistance (Samuelsson, 2015).
Because of the shame and stigma associated with substance use disorders, women
hesitate to seek treatment, resulting in experiencing higher levels of severity
(Samuelsson, 2015). However, when women do take advantage of treatment they
gravitate towards outpatient services (Choi et al., 2015; Yeom, 2015). When in treatment,
women were actively engaged in the counseling process and used the services provided
to them (Choi et al., 2015). They also seemed to benefit more from single-gender groups
(Choi et al., 2015). Haseltine (2000) reported practitioners should have an awareness that
women are internal thinkers and tend to self-medicate as a coping mechanism more than
men do. Haseltine (2000) further stated women display more emotionality and are at
greater risk of committing suicide.
Women face more barriers when seeking treatment (Green, 2006; McNeese-Smith
et al., 2009). For example, women contend with a lack of childcare and lack of
employment (Green, 2006; Mahmood, 2013; Shannon et al., 2014). Women have
difficulty coping with their histories of physical or sexual abuse, poverty, and instability
with housing, mental health issues, along with shame when seeking treatment (Mahmood,
2013; McNeese-Smith et al., 2009; Samuelsson, 2015; Shannon et al., 2014). Even with
these barriers, women who completed treatment remained abstinent longer than women
who did not complete treatment (Green, 2006).
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Haseltine (2000) reported women experience repetitive cycles of relapse from
treatment while facing the stigma characterized by the public as addicts. To understand
why relapses continued to occur, researchers explored the brains' biochemistry. They
found women’s brain are organized different from men. For example, when interpreting
word patterns, women use their left inferior frontal gyrus and their right hemisphere
homolog to perform the same function as men.
To sustain treatment retention, some programs implemented therapeutic alliance
models which focused on person-centered care, gender specific interventions, inclusion in
treatment, and a host of other biopsychosocial interventions (Choi et al., 2015).
Regardless of the services provided, reasons for retention success among women varied
depending on the study (McNeese-Smith et al., 2009). Studies conducted by Green
(2006) and McNeese-Smith et al. (2009) suggested retention success is due to women
having fewer problems associated with their drug use and with mental health issues.
Income and the ability to pay for services due to insurance coverage were additional
factors (McNeese-Smith et al., 2009). McNeese-Smith et al. (2009) indicated predictors
of retention success included the woman’s single marital status, not being African
American, or unemployed. Choi et al. (2015) agreed employment and higher incomes
increased the possibility of success. A third study indicated legal referrals for treatment
added to positive retention rates. Overall, both women and men had consistent treatment
success when comparing retention rates, percentages of treatment completion, and longterm outcomes (McNeese-Smith et al., 2009). However, women tended to remain
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abstinent longer, and relapsing increased when exposed to substance abusing romantic
partners or when they experienced overwhelming personal problems (McNeese-Smith et
al., 2009).
Mahmood et al. (2013) reported 69% of women in prison had substance use
disorders diagnoses and had a higher rate of substance dependence than male prisoners.
Mahmood et al. (2013) further reported from 1977 to 2007 the population of women in
prison grew by eight hundred and thirty-two. Researchers indicated no differences in
recidivism based on gender (Chen, 2009; Mahmood et al., 2013). Chen (2009) reported
women abused drugs more than men during their incarceration, which made substance
abuse an ongoing concern in prisons. Over 80% began abusing drugs within six months
of returning to prison and 65% abused cocaine (Chen, 2009). Women who did not abuse
drugs while incarcerated attributed their abstinence to lower coherence, greater levels of
anxiety, and a higher potential for becoming victims of sexual assault (Chen, 2009).
Minority women experienced greater vulnerability as they represented 70% of the prison
population (Chen, 2009).
When focusing on treatment interventions, traditionally, women receive more
attention than their male counterparts (Samuelsson et al., 2015). Researchers examining
treatment outcomes in prison indicated gender played a significant role in achieving
success (Shannon et al., 2014). Chen (2009) posted a need for “separate gender-oriented
therapeutic interventions” (p.255). Mahmood et al. (2013) reported starting treatment in
prison should transition into their lives upon their release. However, traditional treatment
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approaches such as residential programs and community-based programs have not been
successful for this population once they completed their period of incarceration
(Mahmood et al., 2013). Their utilization of services is a strong predictor of whether they
will have successful outcomes (Shannon et al., 2014; Yeom, 2015). Choi et al. (2015)
reported completion of drug court programs assisted with women in decreasing the
likelihood of relapse.
There are commonalities among gender that influenced outcomes, such as the
person’s age, primary drug, the level of education, employment status, and criminal
history (Shannon et al., 2014). Mahmood et al. (2013) suggested treatment programs
should focus on peer relationships among women with similar backgrounds. However,
Green (2006) reported treatment programs that focused on specific genders bared similar
outcomes as those serving both genders. Green (2006) suggested identifying triggers and
outcomes throughout the treatment process. Brief low-cost interventions demonstrated
positive outcomes for women (McNeese-Smith et al., 2009). Examples include
interventions providing computer literacy and case management services for women on
welfare (McNeese-Smith et al., 2009). Shannon et al. (2014) reported programs focusing
on strengthening family relations, attending to medical issues and mental health concerns,
along with drug abuse, resulted in positive post-treatment outcomes.
Men. In the United States, men represented 1,072,049 (66%) admissions out of
1,614,358 admissions into treatment programs (SAMHSA, 2016d). Among this population,
the average age for men who used some form of stimulant was 33 years old for
Methamphetamine and 44 years old for cocaine (SAMHSA, 2016d). The average age for
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narcotic use was 34 years old for heroin and 33 years old for opiates (SAMHSA, 2016d). In
2014, men in California represented 100,567 (64%) admissions out of 158,434 admissions
into treatment programs (SAMHSA, 2016d). Among these men, 27,214 reported
Methamphetamines were the primary drug, 26,311 reported heroin was the primary drug,
4390 reported opiates were the primary drug, and 4365 reported crack cocaine or cocaine
were the primary drug. Shannon et al. (2014) indicated age was a predictor for reduced
recidivism. Men abused narcotics more than women and had an 11% higher rate of abusing
illegal and legal drugs than women (Samuelsson, 2015; Shannon et al., 2014).

As referred to earlier, the Lev-Ran et al. (2013) study examined gender
differences in the prevalence of substance use disorders among 11 substances: heroin,
cocaine, cannabis, nicotine, alcohol, hallucinogens, inhalants sedatives, tranquilizers,
opioids, and amphetamines. They found cannabis was the most commonly abused
substance in male populations while heroin was the least abused (Lev-Ran et al., 2013).
The researchers indicated men had a higher lifetime prevalence for all the substances
included in the study. Men suffered from substance use disorders more than women and
demonstrated higher rates of substance use disorders from prescription drugs (Lev-ran et
al., 2013; Steingrimsson, Carlsen, Sigfusson, & Magnusson, 2012). Although men were
less likely to abuse prescription drugs, the prevalence of prescription drug use that
developed into a substance use disorder was higher for men (Lev-Ran et al., 2013;
Nelson-Zlupko et al., 1995).
Haseltine (2000) revealed men experienced repetitive cycles of relapse from
treatment while facing the stigma characterized by the public as addicts. To understand
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patterns of behavior and why relapses continued to occur, researchers explored the brains'
biochemistry. They reported men’s brain organization interpreted word patterns by using
more of their left inferior frontal gyrus, similar to women.
Hatgis et al. (2008) reported when considering gender differences; people held
men more accountable for making poor judgments. Haseltine (2000) argued the opposite.
He stated men do not face as much criticism as women. Problems for males was related
to the type of alcohol or substance used.
When examining the lack of treatment success and low retention rates, historically
men performed better than women in alcohol and other drugs treatment programs
(Nelson-Zlupko et al., 1995). Pressure from family and social institutions seemed to be
what caused men to initiate a search for treatment (Haseltine, 2000). When men entered
treatment, the focus was on employment and education, not trauma (Samuelsson et al.,
2015). Employed Caucasian men had better attendance and longer retention rates.
Additionally, having an adequate income and medical insurance to pay for treatment had
a positive correlation with high retention rates for men (McNeese-Smith et al., 2009).
A factor predicting success with retention for men was age. Researchers
documented the older the man, the better success they had with staying in treatment
(McNeese-Smith et al., 2009). Men referred by their employer also reported positive
retention rates (McNeese-Smith et al., 2009). Most importantly, having goals associated
with abstinence increased retention success for men (Choi et al., 2015). Choi et al. (2015)
reported men’s length of stay in treatment programs predicted lower rates of substance
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use once out of treatment, along with decreased recidivism rates. Choi et al. (2015) also
reported men who left treatment before completion experienced unfavorable treatment
outcomes.
Primary drug use co-occurring with a mental health diagnosis proved to be a
predictor of shorter retention rates for those who abused cocaine (Choi et al., 2015).
However, men’s problems stemming from substance abuse were less problematic than
those experienced by women (Samuelsson et al., 2015). Practitioners should understand
that men are external thinkers, social, and used drugs as a form of exploration (Haseltine,
2000). Shannon et al. (2014) found men were more active in criminal activities and
committed their first crime 10.4 years younger than women did. However, when
comparing recidivism rates, there was no differences based on gender (Chen, 2009).
When examining the rate of drugs used among men in prison, Mahmood et al. (2013)
reported men abused drugs at a higher rate than women. However, Chen (2009) indicated
men remained abstinent for longer periods due to higher coherence, lower anxiety levels,
and less hostile feelings. When men exited the legal system, they returned within two
years (Shannon et al., 2014).
Chen (2009) posited the need for “separate gender-oriented therapeutic
interventions” (p. 255). However, treatment programs focused on specific genders
resulted in similar outcomes compared to treatment programs that serve both genders
(Green, 2006). Shannon et al. (2014) reported significant success with post-treatment
outcomes for both genders across treatment modalities. As a result, Green (2006)
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suggested the focus should be on a need for treatment providers to focus on identifying
triggers throughout the duration of services. Regardless of gender, there were several
factors requiring attention when considering the need for positive outcomes, such as the
person’s employment status, primary drug, the level of education, and criminal history
(McNeeses-Smith et al., 2009; Shannon et al., 2014). Practitioners should assure clients
establish a goal of abstinence while receiving services (McNeese-Smith at al., 2009).
In conclusion, practitioners should be aware of the differences between genders
when treating substance use disorders. Women are more likely to abuse licit drugs while
men are more likely to abuse illicit drugs (Nelson-Zlupko et al., 1995). Practitioners
should also apply various types of treatment interventions for each patient, taking into
account their biopsychosocial needs that include age, ethnicity, gender, life experiences,
trauma, and treatment history that would influence attrition rates (Samuelsson et al.,
2015). Researchers demonstrated treatment services pathologize women’s substance
abuse and dependence while underestimating the needs of men (Samuelsson et al., 2015).
Practitioners should be mindful of their personal biases and prejudices which marginalize
and stigmatize men and women (Samuelsson et al., 2015).
Treatments for Substance Use Disorders
Mennis et al. (2012) reported 205 million people worldwide abused drugs in
2012, of which 35% to 85% did not receive treatment. The National Survey of Substance
Abuse Treatment Services revealed from 2008 to 2012, 23.9 million Americans used
illegal drugs, 9.2% of the total population (Cummins et al., 2009; Stanforth et al., 2016).
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SAMHSA (2016b) examined opiate abuse in 2014. The report revealed 4.8 million
Americans used heroin at least once that year and 4.3 million Americans abused
prescription opioids or opiates. Banta-Green, Maynard, Koepsell, Wells, and Donovan
(2009) documented the availability of prescription opioids resulted in an increased
number of admissions into treatment programs across the United States from 0.9% to
4.2% in 2006. Baird (2015) reported the Division of Pharmacological Therapy oversees
1250 opiate treatment programs in the United States who provided services to
approximately 300,000 patients each year. Providers anticipated a need for increased
services would continue to rise as the number of reported abusers of prescription opioids
increased.
The Center for Behavioral Health Statistic and Quality (2015) reported 1.6 million
Americans abused prescription stimulants, of which 569,000, or one-third were
homemade Methamphetamines. SAMHSA (2013a) indicated 947,000 people were
dependent on or abused illegal drugs, but only 117,000 received treatment. In 2014,
SAMHSA’s (2016c) longitudinal study spanning from 2004 to 2014 reported 1,614,358
admissions for five primary drugs, 36% to treat alcohol abuse, 30% for opiates and heroin
abuse, 15% marijuana abuse, 15% Methamphetamine and amphetamine abuse, and 5%
for cocaine and crack cocaine abuse.
There are four types of treatment programs that address substance use disorders.
SAMHSA (2016c) listed them as: Ambulatory, an outpatient treatment service that
includes individual or group treatment and pharmacological therapy. This category also

66
includes intense outpatient treatment requiring two or more hours of treatment per day for
at least three or more days per week. Detoxification could include 24-hour treatment in a
residential facility or a hospital. This category also includes ambulatory outpatient
treatment with or without pharmacological therapy. Rehabilitation includes residential
short-term (30 days or less) or long-term (more than 30 days), or rehabilitation in the
hospital for 24 hours. Medication-assisted opioid therapy consists of pharmacological
therapy (methadone or buprenorphine) provided in an outpatient setting that could be
intensive outpatient or detoxification program in a residential facility, hospital or
ambulatory. Treatment could be administered during residential short or long-term
programs or inpatient hospital treatment.
SAMHSA (2016c) conducted a longitudinal study in the United States spanning
from 2004 to 2014. There were 1,614,358 admissions into treatment programs for alcohol
abuse, opiate and heroin abuse, marijuana abuse, Methamphetamine and amphetamine
abuse, and cocaine and crack cocaine abuse. SAMHSA (2016c) also reported opiates
increased from 3% in 2004 to 8% in 2014. Opiate as the primary drug represented 19% of
opiate admissions in 2004 and 27% in 2014. In 2014, men represented 53% of admissions
for opiate treatment with an average age of 33 years old. Eighty-four percent of those
admitted into treatment in 2014 were White. The primary route of use for 60% of those
reporting opiate abuse used oral methods, and 17% reported inhalation as their route of
choice.
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SAMHSA (2016c) reported, admission into treatment for heroin abuse increased
by 36% from 262,518 admissions in 2004 to 357,293 admissions in 2014. This
represented an increase from 15% in 2004 to 22% in 2014 (SAMHSA, 2016c). Heroin as
a primary drug represented 81% of the opiate admission in 2004 but decreased to 73% in
2014 with the average age at 34 years old. Two-thirds of heroin users were males, 69%
were White, 14% were Hispanic, and 12 % were Black. The preferred routes of use were
injection at 72% and inhalation at 22% (SAMHSA, 2016c).
SAMHSA (2016c) also reported, during 2004 cocaine admissions decreased from
14% to 5% in 2014. Crack cocaine as the primary drug represented 72% of cocaine
admission in 2004 and 66% in 2014. The average age of crack cocaine users was 44 years
old, and the average age for cocaine users was 38 years old. Of the total number of
people who used crack cocaine, Blacks represented 56%, Whites at 32%, and Hispanics
eight percent. Cocaine users consisted of 34% Blacks, 43% Whites, and 19% Hispanic.
Inhalation was the primary route of use for 79%, while 11% preferred injection.
SAMHSA (2013a) reported during the year 2012, there were 1,611 treatment
facilities in California, which offered opiate treatment programs, and 125,756 patients
received treatment. A study conducted by SAMHSA (2015) indicated of the 158,435
Californians who received treatment for substance use disorders, 46,754 were for
narcotics abuse, and 54,756 were for stimulants abuse. SAMHSA (2015) reported the
increase of treatment facilities appeared to have had a significant impact.
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As indicated above, in the United States men entered treatment more than women
(SAMHSA, 2016c). For example, in California a disproportionate number of men entered
treatment at a higher rate than women (SAMHSA, 2016d). SAMHSA (2016d) reported
California had 158,434 admissions in 2014 for substance use disorders, which included
100,567 admissions initiated by men and 57,781 admissions initiated by women. When
examining primary drug and gender, men represented 26,311 admissions into treatment
for heroin compared to 11,959 admissions by women. Opiate admissions were about
equal with 4,390 admissions initiated by men and 4,074 admissions initiated by women.
Men had a slight edge with Methamphetamine and amphetamine admissions with 27,214
treatment attempts compared to 21,084 treatment attempts by women. For crack cocaine,
men were responsible for 3,163 admissions while women represented 1,670 admissions.
Cocaine also indicated men seeking treatment more often with 1,202 admissions
compared to 337 admissions initiated by women. Therefore, a need exists for alternative
treatment approaches to attract and retain women in treatment (Nelson-Zlupko et al.,
1995).
Retention in treatment programs was a growing concern and a focus for BantaGreen et al. (2009) as they examined whether people who choose prescription opioids as
their primary drug stayed in treatment longer than people who choose heroin. BantaGreen et al. (2009) demonstrated that people who abused prescription opiates had better
retention rates than heroin abusers, due to fewer health problems and better social
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stability. However, heroin users in methadone treatment programs tend to do better in
treatment with adequate doses of methadone (Bao et al., 2009).
Treatment Approaches
Addictive behaviors encompass a constellation of maladaptive behaviors due to
people’s inability to self-regulate or control impulses when faced with internal and
external stimuli, despite consequences of acting on these impulses (Grant et al., 2010;
Rotter, 1966; Sheffer et al., 2012; Webb et al., 2010). In the addiction field, the question
as to what type of treatment intervention works (12 step programs or empirically based
techniques; such as harm reduction and biopsychosocial methods) is secondary to
understanding the patient and the disorder (Bristow-Braitman, 1995).
Opiate and Opioid drug abuse is, “a major health and social burden” (Bao et al.,
2009, p. 28). In 2000, there were 179,000 patients enrolled in methadone maintenance
treatment programs in the United States (Scimeca et al., 2000). Methadone maintenance
treatment programs provide methadone to patients with opioid and opiate dependence to
prevent withdrawal (Bao et al., 2009). Bao et al. (2009) reported higher doses of
methadone correlate with high retention rates, while high dropout rates are due to low
doses of methadone. Banta-Green et al. (2009) reported treatment availability for
prescription opiate users increased in the United States from 0.9% to 4.2% in 2006 and
was anticipated to continue to rise as the need for treatment increased with the escalating
rates of prescription abuse.
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Banta-Green et al. (2009) emphasized how essential it is for effective treatment to
be available for this growing population. Most concerning for Banta-Green et al. (2009)
were the retention rates in treatment programs across modalities. Hall (2001) also
expressed concern about retention rates among people diagnosed with substance use
disorders. Hall (2001) hoped the administration of the DRLOC scale would help increase
these rates across treatment modalities. Banta-Green et al. (2009) focused on the type of
drug used to gain an understanding of retention rates among narcotic abusers. BantaGreen et al. (2009) found patients who used prescription opiate as their primary drug
stayed in treatment longer than patients who used heroin as their primary drug.
Furthermore, there were better retention rates for patients with a history of prescription
opiates than with a history of heroin due to fewer health problems and better social
stability (Banta-Green et al., 2009).
Practitioners and researchers continued to discover methods to treat addiction.
From traditional treatment approaches, such as harm reduction (Rosenberg & Phillips,
2003), to the latest innovative approach to treatment, such as immunotherapy (ZalewskaKaszubska, 2015), the field of addiction continues to change as counseling techniques
and medical approaches show a significant difference in patient’s quality of life.
Therefore, it is necessary to assess a person’s readiness to change behaviors associated
with their primary drug and measurement of meaningful change in their Quality of life
(Hall, 2001; Pasareanu et al., 2015). Lubman et al. (2004) indicated change is not easy
and requires the belief that change could occur. It also requires motivation that drives a
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person toward changing maladaptive behaviors and discipline to maintain a level of
control over the impulsivity that feeds addictive behaviors (Lubman et al., 2004).
Patient-Centered Care. Davidson et al. (2008), as well as other researchers, such
as Larkin et al. (2006), encouraged individuals, organizations, and the healthcare field to
demonstrate a positive shift in how they treat patients with addictions. They encouraged
practitioners in medical and mental health settings to become more person-centered,
compared to focusing on a patient’s diagnosis or disorder. Person-centered or clientcentered care allows for individualized treatment plans and research approaches.
Rogers (1992) introduced the original concept of patient-centered or clientcentered care as a theory. The theory consisted of six components: Recognizing there is
an interaction between the two parties; patients and practitioners. Recognizing the
presence of incongruence, meaning how the patient views his experience compared to the
actual experience. The practitioner’s acceptance and awareness of self and staying true
and genuine to who he is as an individual. The practitioner’s unconditional acceptance of
the patient, meaning acceptance and caring for the patient as an individual. The
practitioner’s ability to have and express empathy, meaning meeting the patient where he
is in his understanding of self and the experience that brought him into treatment. The
patient’s perception of the practitioner, meaning the patient awareness of the
practitioner’s acceptance of the patient and his situation and the empathy the practitioner
presents.
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According to Kirschenbaum and Jourdan (2005), over the years since the
introduction of Rogers’ theory of patient-centered care, researchers have narrowed these
six elements down to three main components, “empathy, unconditional positive regard,
and positively congruent” (p. 37). Incorporating the patient-centered approach across
mental health and addiction settings could help diminish the underlining stigma
associated with substance use disorders. This individualized approach to treatment aligns
with individualized assessments. Along with cognitive behavioral therapy techniques,
motivational interviewing, and several other evidence-based strategies, an individualized
assessment helps practitioners learn more about the patient to develop a rapport that is
supportive and less punitive (NIDA, 2008).
Conceptual Framework
Rotter (1966) explained the way people react to a situation or event depends on
how much control they believe they have over the situation or event and their
expectations of the outcomes. Rotter (1966) further explained the person’s past helps to
determine whether they experienced positive or negative reactions to current, similar
experiences. Because of past experiences, the person expects similar outcomes in the
future (Rotter, 1966). Rotter (1966) termed this generalized expectancy. To measure
generalized expectancy and how much control people feel they have over current
situations or events, Rotter and Mulry (1965) developed the Internal-External Locus of
control (I-E LOC) scale. The I-E LOC scale was a unidimensional tool that provided a
generalized assessment of LOC.
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Over the years, researchers modified the I-E LOC scale from a unidimensional
generalized instrument for measuring people’s response to life’s experiences to a
multidimensional instrument targeting specific domains or topic of interest. For example,
Keller and Blomann (2008) modified versions of the generalized I-E LOC scale to
measure skills demand in the workforce and the health status of veterans (Marshall et
al.,1990). In the field of addiction, Keyson and Janda (1972) modified the I-E LOC scale
to address alcoholism by developing the Drinking Related Internal-External (DRIE)
scale. Hall (2001) further modified the DRIE scale to develop an individualized
instrument called the DRLOC scale, which addresses substance abuse.
Hall’s LOC Study
Rotter (1966) developed generalized expectancy theory and the I-E LOC
construct. The I-E LOC scale did prove useful in the area of addiction for some
researchers. Researchers examined the relationship between LOC and narcotics, LOC and
alcohol, and LOC and alcohol and other drugs (Berzins & Ross 1973; Calicchia, 1974;
Cox & Luhrs, 1978; Rotter, 1966). Researchers addressed the limitations of the I-E LOC
scale as a unidimensional instrument and its inability to transition from an individualist to
a collectivist culture (Lefcourt, Von Baeyer, Ware, & Cox, 1979; Marshall et al., 1990;
Smith et al., 1995). Hall (2001) concurred with the critics of the I-E LOC scale and set
out to develop a domain-specific, individualized instrument to measure LOC (Bright,
Kane, March, & Bishop, 2013; Hattrup, O’Connell, & Labrador, 2005; Lefcourt, 1992;
Smith et al., 1995).
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Keyson and Janda (1972) explored the concept of LOC related to alcohol abuse to
develop the DRIE scale. The researchers translated the I-E LOC scale from a
measurement of expectancy in the general population to an instrument that would
measure expectancies of an individual (Davis et al., 2014; Keyson & Janda, 1972). There
have been numerous studies examining the relationship between alcohol usage and LOC,
but little research exists related to substance abuse and LOC (Hall, 2001). Hall (2001)
wanted to explore how people with substance use disorders make decisions related to
drug use and the concerns directly related to substance abuse, such as the relationship
between self-esteem and low retention rates in treatment programs. To get a more
accurate measurement of LOC in the substance use disorder population, Hall (2001)
modified the DRIE instrument by changing the words on the DRIE associated with
alcohol to words related to drugs. Hall (2001) called the new LOC instrument the
DRLOC scale for assessing LOC in patients with substance use disorders. Hall (2001)
argued an individualized assessment of LOC compared to a generalized assessment of
LOC could provide a better predictor of treatment outcomes in men and women
diagnosed with substance use disorders.
Hall (2001) and Davis et al. (2014) identified the DRIE scale as one of the first
internal-external instruments modified from Rotter’s original generalized I-E LOC scale,
to measure a specific factor in the field of addiction. The DRIE scale measured people’s
perception of how much control they have over their behaviors associated with drinking
alcohol and the recovery process (Davis et al., 2014). In 1978, Donovan and O’Leary
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conducted a study to measure the reliability of the DRIE scale (Davis et al., 2014).
Compared to other control-oriented instruments, the DRIE showed a significant
correlation supporting the validity of the instrument and demonstrated “high-level test
reliability alpha and Kuder-Richardson coefficients of internal consistency of .77” (Davis
et al., 2014, p. 875). Research conducted using the DRIE scale demonstrated scores that
discriminate between people who identify as being dependent on substances and those
who identify as non-dependent on substances (Davis et al., 2014). Furthermore,
measurements from the DRIE scale have proven to predict substance use behaviors after
treatment (Davis et al., 2014).
The DRIE consists of 25 items and is a forced-choice instrument, with a score of
two representing an external-LOC and a score of one representing an internal-LOC (Hall,
2001; Davis et al., 2014). With forced-choice instruments, participants must choose
between two sets of statements presented to determine which more closely represents
their belief system or behavior (Davis et al., 2014).
Hall (2001) modified the DRIE scale to measure expectations related to substance
abuse. The goal was to transform the DRIE scale into a shorter version associated with
drug use. To do this, Hall examined the analysis of the DRIE scale generated by Donovan
and O’Leary in 1978. Hall selected 15 items from the DRIE instrument with high-factor
loading and adjusted the questions by changing words related to alcohol with words
related to drugs to create a forced-choice, internal-external instrument. Hall called the
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instrument the DRLOC scale. The purpose of the DRLOC scale was to identify belief
systems related to primary drug use by measuring expectancies related to drug use.
Hall’s (2001) DRLOC scale (Appendix B) includes statements that measure drug
use expectancies in drug-related situations to determine LOC. Forced choice items give
two statements per item forcing the participant to choose one of the two statements. An
example of a forced-choice item with two statements is item number six on the DRLOC;
successfully kicking substance abuse is a matter of demanding work. The two statements
presented are, A) luck has little or nothing to do with it, and B) staying clean depends
mainly on things going right for you. Item A equal one point and item B equal 2 points.
After the participant completes the instrument, the interviewer adds the numbers circled
by the participant and divides the sum by 15 (the total number of items on the scale) to
get the mean score. A score that is closer to one represents a more internally controlled
locus, and a score that is closer to two indicate a more external locus. People with an
internal-LOC score are more likely to be actively engaged, alert, and spontaneous people,
trying to achieve their goals. They quickly and emotionally adjust with stronger
interpersonal skills, actively seeks information, has a higher sense of self, and can make
decisions independently. People identified as having an external-LOC score are more
prone to be more depressed, have anxiety, and have limited abilities to cope with daily
stressors.
After an exhaustive literature search, I found Ersche et al. (2012) was the most
recent study using the DRLOC. Ersche et al. (2012) did a factor analysis of the DRLOC
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scale by comparing it to Rotter’s and Mulry’s (1965) I-E LOC scale. Their study
consisted of 592 volunteers, of which 282 were receiving treatment for narcotics,
stimulants, or alcohol, while 310 reported no drug history and identified themselves as
professionals and nonprofessionals. Among the participants of both groups, age and
ethnicity did not vary significantly. However, gender was slightly different with 46% of
men and 54% of females participating in the control group with no history of drug use
represented. The percentage of men in the group with a history of drug use was 75%
while women represented 25%.
The DRLOC scale has proven to be an appropriate instrument that could benefit
patients and practitioners (Escher et al., 2012). Many studies have demonstrated one’s
LOC orientation shifts during the therapeutic process (Page & Scalora, 2004). Page and
Scalora (2004) suggested that practitioners measure LOC from an external to internal
shift while in treatment. The score thus becomes an indicator that the assigned
interventions were a viable treatment strategy. Therefore, measuring shifts in LOC would
help patients and practitioners develop appropriate interventions throughout the recovery
process (Scimeca et al., 2000).
Researchers stated those who are diagnosed with substance use disorders are so
because of their chronic relapsing patterns of behaviors. People who are diagnosed with
substance use disorder continued to use regardless of the consequences to their health or
productivity (Davidson et al., 2008; Gifford & Humphreys, 2007; Grant et al., 2010;
Vohs & Baumeister, 2009). Examining one’s cognitive processes related to substance
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abuse is important to understanding multiple relapses and appropriate treatment. Ersche
et al. (2012) explained that the DRLOC scale could effectively measure people’s
perception of impulse control over addictive behaviors. Ersche et al.’s (2012) study
demonstrated a reliability of the DRLOC instrument at .81 for measuring thought
processes. Therefore, utilizing the DRLOC scale during treatment could help
practitioners understand patients thought processes related to their drug use, thereby
helping practitioners develop appropriate interventions to meet the patient’s individual
needs (Ersche et al., 2012).
Internal-External Locus of Control Scale
The conceptualization for LOC consists of a bipolar construct spanning the
spectrum from internal control to external control. People with an internal-LOC have an
awareness and acceptance of positive or negative consequences resulting from their
behaviors, while people with an external-LOC attribute achievements or lack of success
to actions out of their control (Page & Scalora, 2004).
Some of the studies with the I-E Control scale explored task structure and I-E
Control (Lefcourt, 1966). In 1955, one study examined interpersonal variables and I-E
Control (Lefcourt, 1966). During 1959 to 1965, researchers explored the I-E Control and
conformity and from 1960 to 1965 additional studies explored risk-taking and I-E Control
(Lefcourt, 1966). The I-E Control research showed the construct of control or one’s
perceived control would be very useful in understanding behavior (Lefcourt, 1966). In
fact, during the first 30 years of its conception, the construct of I-E Control and
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expectancy were the most cited topics in the psychology and social science field with
4700 citations in Monograph since the first expository paper written by Rotter, Seeman,
and Liverant in 1962 (Rotter, 1990).
Rotter and Mulry (1965) continued to research the I-E Control scale by
administering the scale to college students (N = 120). There were 61 women, and 59 men
participated in the studies as part of the entry-level psychology course. Researchers
randomly assigned participates in two groups: an internal group (skill group), and an
external group (chance group). The external group was the control group. The experiment
consisted of angle matching tests of problems designed to be difficult. The researchers
informed one-half of the sample group that the choices would be extremely difficult and
would require luck to achieve the goal of discriminating. The other half of the sample
group was informed that prior studies showed their choice might be difficult but with
skill, one could achieve the goal of discriminating.
Two researchers conducted the study and asked the participants if they felt they
would be successful in getting the trail correct during the next trail on a scale of 0 to 10.
The researchers administered the I-E Control scale to half the participants before
conducting the main experiment, and then after the main experiment administered the I-E
Control scale to the other participants. The researchers did not score the results of the
instruments. Instead, they took the participants and alternately placed them in either the
change group or the skill group.
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The second part of the study consisted of two procedures. One training consisted
of eight trials. During these trials, all participants received equal reinforcements and then
informed of being correct 75% of the time. The second part consisted of interviewers
informing participants during the second and the fourth trials that they made wrong
choices. Afterward, the final stage of the study included the extinction phase consisting
of 50 consecutive trials. During this part of the experiment, each participant was told they
were wrong everytime. If participants responded with 0 or 1 to the likelihood they would
get the next trail correct, the study for that person ended.
The study resulted in an average score of 8.48 for the I-E Control scale, and a
medium score of 8.0. The researchers identified mean scores nine or more as external
thinkers and people who scored eight or less as internal thinkers. The overall result of the
study concluded that participants instructed with chance discrimination resulted in 29
internal thinkers and 19 external thinkers. Participants instructed with skills
discrimination resulted in 36 internal thinkers and 26 external thinkers. Rotter and Mulry
(1965) indicated the results showed no significant difference between men and women.
Informing internal thinkers that the tasks required skills slowed their decision-making
process. External thinkers took longer to decide when told luck or chance was the
determining factor.
As a result of this study, the I-E Control scale was renamed the I-E LOC scale and
then published in 1965 by Rotter and Mulry. The goal of Rotter and Mulry was to find a
more specific way of predicting reinforcement’s influence on expectancies. The intent
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was to have a low correlation with other scales used to measure behaviors (Rotter, 1966).
Most importantly, the I-E LOC scale predicts and gauges behaviors across a broad range
of potential situations and disciplines, and with no expectations of high internal
consistency (Smith et al., 1995).
Over the years, researchers in the psychology and social science fields extensively
studied the I-E LOC constructs with a focus on individualizing domains instead of
limiting the scope to general topics (Hall, 2001; Page & Scalora, 2004). For example,
researchers viewed the I-E LOC scale as a unidimensional instrument with a narrow
scope of questions on several topics, of which drew lots of criticism. From this criticism,
researchers started to modify the I-E LOC scale by creating a multidimensional
instrument that provides broader questions for a specific topic (Hattrup et al., 2005;
Lefcourt, 1992; Smith et al., 1995). Examples of some topics included happiness
(Pannells & Claxton, 2008), anger and impulsivity (Deming & Lochman, 2008),
communication (Lam & Mizerski, 2005), conscientiousness (Hattrup et al., 2005), Health
(Marshall et al., 1990) productivity in the workplace and job performance (Forte, 2005;
Smith et al., 1995).
Rotter (1966) further emphasized people who accepted their history of repeated
failures due to events out of their control, could obtain a sense of control over what
happens to them in the future. On the other hand, the researcher also explained, people
who feel they have total control of their life, learn, in the face of adversity, there are
things they cannot control.
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Because of internal and external factors that influence people’s behaviors, Bright
et al. (2013) supported an individualized instrument and suggested a LOC instrument
focused on a specified area would be more useful than a global instrument that covers
multiple domains. Hall’s (2001) DRLOC scale is an example of an individualized,
multidimensional instrument, which focused on one domain, substance use disorders, and
has demonstrated high capabilities for predicting outcomes compared to a generalized,
unidimensional instrument like the I-E LOC scale (Ersche et al., 2012).
Summary
Addiction is best defined as being a brain disorder or neurological disease caused
by molecular changes in the brain’s chemistry due to foreign chemicals introduced into
the system (Caan, 2012). Addictive Behaviors encompass a constellation of maladaptive
behaviors forcing patients to lose control over their actions and their ability to think
rationally regardless of negative consequences (DEA, 2013; Gifford & Humphreys, 2007;
Grant et al., 2010; Sheffer et al., 2012). Mennis et al. (2012) reported 205 million people
worldwide abused drugs in 2012, of which 35% to 85% did not receive treatment. The
National Survey of Substance Abuse Treatment Services revealed from 2008 to 2012,
23.9 million Americans used illegal drugs, 9.2% of the total population (Stanforth et al.,
2016; Cummins et al., 2009). According to reports in California, approximately 876,000
Californians used and abused illicit drugs in 2014 (SAMHSA, 2015a).
The newest paths scientists and researchers take explores the influence of
addictive behaviors by examining neurobiology and genetic variations (Davidson et al.,
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2008; NIDA, 2014). They seek to understand the brain’s dysfunctions and how the brain
influences compulsive and impulsive patterns of addictive behaviors (Lubman et al.,
2004).
In the field of addiction treatment, there are four main types of treatment
modalities: ambulatory, detoxification, rehabilitation therapy, and medication-assisted
opioid (SAMHSA, 2016c). The question as to what type of treatment intervention works
is secondary to understanding the patient and the disorder (Bristow-Braitman, 1995).
Recognizing the role gender has in substance use disorders is important when deciding
interventions. Nelson-Zlupko et al. (1995) reported on the differences between genders
related to chemical addictions. Haseltine (2000) reported men used drugs as a form of
exploration while women tend to self-medicate as a coping mechanism. Haseltine (2000)
further reported women are internal thinkers and are more likely to abuse licit drugs
while men are more external thinkers and are more likely to abuse illicit drugs.
It is necessary to assess a person’s readiness to change behaviors associated with
their primary drug and measure significant changes in their quality of life (Hall, 2001;
Pasareanu et al., 2015). Incorporating a person-centered approach to addiction treatment
could help diminish the underlining stigma associated with substance use disorders and
bring more people into treatment (Davidson et al., 2008; Kirschenbaum & Jourdan, 2005;
Larkin et al., 2006). Providing an individualized approach to treatment aligns with the
implementation of individualized pre and post assessments (Foon, 1986; Hall, 2001). Pre
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and post assessments help measure progress in treatment and success with individualized
interventions and could assist in the development of future services (Foon, 1986).
One tool that could help measure progress in treatment is the DRLOC scale.
According to Rotter (1966), LOC refers to people’s perception of control based on past
experiences and internal or external reinforcement in the environment. When applied to
addiction and addictive behaviors, the amount of control or lack of control they had over
the outcome of a similar event determined the patients’ level of expectancy for positive or
negative reinforcements (Rotter, 1966). Hall (2001) argued an individualized assessment
of LOC compared to a generalized assessment of LOC could result in a better predictor
of treatment outcomes (Rotter, 1966). As a result, Hall (2001) developed the DRLOC
scale for assessing LOC in patients with substance use disorders.
The goal of this pre-experimental, quantitative study was to explore the potential
relationship between LOC and primary drug use among men and women who had been
diagnosed with a substance use disorders. I utilized secondary data from a study
conducted by Hall (2001) titled, Feelings About Drug Use, Drug-Related Locus of
Control, that examined men and women diagnosed with a substance use disorder by
administering the DRLOC instrument. The methodological choices, as well as procedures
I used to collect and analyze this data is detailed in chapter 3.
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Chapter 3: Research Methodology
The purpose of conducting this study was to closely examine some of the data
generated by Hall’s DRLOC study. Hall developed and administered the DRLOC scale,
which is an individualized assessment tool that measures LOC in patients diagnosed with
substance use disorders. In this chapter, I provided a detailed description of Hall’s
DRLOC study and the UCLAs Integrated Substance Abuse Programs’ original study
titled Drug Treatment Process and Drug Treatment Counselor Practices and
Effectiveness. Participants in the Feelings About Drug Use, DRLOC study were recruited
from the Drug Treatment Process and Drug Treatment Counselor Practices and
Effectiveness study. I examined the recruitment process, threats to validity, ethical
procedures, methodology, and data analysis related to Hall’s Feelings About Drug Use,
DRLOC study.
Research Design and Rationale
The current study is a quantitative preexperimental static group comparison
design using secondary data from research conducted by Hall to examine the effect
gender and primary drug use has on DRLOC scores. Hall’s investigation was part of a
larger study conducted by the UCLAs Integrated Substance Abuse Programs’, Drug
Treatment Process and Drug Treatment Counselor Practices and Effectiveness study. The
UCLAs study included 666 participants from 19 treatment programs. In addition to
alcohol, there were responses from people who abused ten types of drugs. They were
amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone,
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methaqualone, opiates, phencyclidine, and propoxyphene (Hall, 2001). Hall (2001)
conducted a follow-up study using 553 of the original 666 participants.
Hall (2001) dealt with whether there was a relationship between LOC scores and
self-esteem in people with substance use disorders and whether the DRLOC scale
outcomes related to retention rates in treatment programs. This current study examined
DRLOC scores by extracting from Hall’s 553 participants a sample size of men and
women who identified narcotics or stimulants as the primary drug for which they were
being treated.
Using the data generated by the UCLAs Integrated Substance Abuse Programs as
secondary data provided an existing structure for proceeding with examining the three
variables presented for the current study. Hall (2001) reported the original study
conducted by the UCLAs Integrated Substance Abuse Programs examined the process
associated with drug treatment and counseling practices, along with their effectiveness in
relation to drug treatment. Hall (2001) examined the usefulness of identifying LOC and
self-esteem as it related to substance abuse. The current study builds on the understanding
gained from these two previous studies by examining the effect gender and primary drug
had on the DRLOC score.
Methodology
Population
I conducted the current study using secondary data generated by the UCLAs
Integrated Substance Abuse Programs’ Drug Treatment Process and Drug Treatment
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Counselor Practices and Effectiveness study. The sample size in the UCLAs study was
666 participants diagnosed with substance use disorders from 19 drug treatment
programs. From the UCLAs Integrated Substance Abuse Programs’ study, 553
participants agreed to participate in Hall’s (2001) Feelings About Drug Use, DRLOC
study.Hall reported among the participants there was a mean age of 36.2 (SD = 9.58), a
mean year of education of 12.2 (SD = 2.47), and a median household income of $10,00014,999. There were more females (n = 300, 54.2%) than males (n = 253, 45.8%), and the
majority of participants were either Caucasian (n = 227, 41.1%), African-American (n =
178, 32.2%), or Latino (n = 103, 18.6%).
Original Study’s Procedures for Recruitment
According to Hall (2001), the UCLAs study recruited participants from 19 drug
treatment programs in Los Angeles County representing five different treatment
modalities: Inpatient and outpatient treatment, residential, day treatment, and methadone
programs. The researchers assured the representative programs reflected proportionately
with each treatment model within Los Angeles County. Each program’s number of
participants proportionally represented the population within their respectful treatment
modality. They randomly selected participants from large programs to assure 30
participants per program. For smaller programs, the staff selected patients to participate,
including new admissions, until they obtained 30 participants. Variations existed among
the programs related to time in treatment and philosophy.
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Of the 666 participants in the University of California Los Angeles study, 101
participants refused to participate in Hall’s (2001) DRLOC study. Additionally, Hall’s
final sample only included those with 12 or more non-missing responses across the 15
DRLOC items, resulting in a final sample of 553 participants. Trained interviewers
conducted the meetings with each participant. The requirements for participation in the
DRLOC study included being in treatment for at least two weeks. The University of
California Los Angeles Integrated Substance Abuse Programs granted permission for
participants recruited from detoxifications programs to participate for 3 to 5 days after
admission into their program. The interviewers held the meetings in private rooms
located at each treatment facility. The interviews lasted approximately 45 minutes, and
each participant received $10 for their participation and $5 for contributing a urine
sample.
Permission to Use Archival Data
The procedure required to obtain approval to use the UCLAs Integrated Substance
Abuse Programs’ data from the Drug Treatment Process and Drug Treatment Counselors
Practices and Effectiveness study, and the Feelings About Drug Use DRLOC study,
consisted of contacting Hall via email with a formal request to use the data from the
Feelings About Drug Use, DRLOC study. Hall provided required documents needing
signature and information from the researcher, the Chair, and representatives of Walden
University’s Institutional Review Board (IRB). Additionally, I obtained approval from
Walden’s IRB by signing the data use agreement to assure proper use of the data. I
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secured all the letters and emails to and from Dr. Hall and official documents in a locked
file in my home office (see Appendix A).
Archival Data Sampling Procedure
Eligible participants from Hall’s data consisted of those with non-missing data on
DRLOC, primary drug, and gender. A filter was created so that only eligible participants
were included in analyses. Hall did not report there was any missing data regarding
DRLOC or gender, so exclusions were based on those whose primary drug was not a
narcotic or stimulant. According to Hall’s codebook, there were three other primary drug
categories: alcohol, marijuana, and other. Hall did not report proportions by primary
drug; however, Spear, Crevecoeur, Rawson, and Clark (2007) reported that 56.6% of
treatment admissions in Los Angeles County between 2001 and 2005 were for narcotic or
stimulant drugs and the remaining 43.4% were for alcohol, marijuana, or other drugs.
Therefore, it was reasonable to expect that of Hall’s 553 participants, half or more were
likely to be eligible for the proposed secondary analyses. Based on a sample size of 402,
a G*Power sensitivity power analysis calculates a 2x2 full factorial ANOVA would
detect as statistically significant (p < .05) a small partial η2 = .02 (Cohen’s f = .13) for a
main effect or interaction.
Instrumentation and Operationalization of Constructs
Hall (2001) developed a LOC instrument called the DRLOC scale modified from
the DRIE scale, which addressed LOC and alcohol. Hall modified the DRIE instrument
by changing the words associated with alcohol to words associated with drugs to develop
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the DRLOC scale. Hall administered the DRLOC scale in a secondary study to
participants who had participated in the Drug Treatment Process and Drug Treatment
Counselor Practices and Effectiveness study conducted by UCLAs Integrated Substance
Abuse Programs (Hall, 2001). The goal of the second study, titled Feelings About Drug
Use, DRLOC, was to measure drug-related LOC in patients receiving treatment for
substance use disorders (Hall, 2001).
The DRLOC scale was the latest LOC instrument in the field of social science,
spanning over 70 years. Hall analysis of the DRLOC instrument found α = .81. Hall
measured internal consistency by applying Cronbach’s alpha and the split-half procedure
using the Spearman-Brown Prophecy formula. Hall explained the Feelings About Drug
Use, DRLOC study was large and hindered the procedure for test-retest reliability and
examined other measures to test convergent validity by examining correlations of scores.
This included participant’s DRLOC score and Addiction Severity Index scores which
positively correlated (r = .301 p <.00). This demonstrated that high scores generated from
the Addiction Severity Test (except for the subscale, Medical) correlated with a high
score from the DRLOC (external-LOC). It should be noted that of the seven domains on
the Addiction Severity Index scale (medical, employment, alcohol and drugs, legal,
family and social relationships, and psychiatric) the subscale of alcohol and drugs
demonstrated the highest correlations with a score of .283.
Hall (2001) reported the results from the DRLOC study indicated men’s LOC
scores were higher than women (p < .01). Mean scores among ethnic groups indicated
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Latino’s scores were significantly high with LOC mean at 1.34, (p < .01). Hall also
reported there was no significant difference in LOC among age groups. However, there
was a significant difference between participants across treatment modality at p < .01.
Hall discussed how participants from hospital inpatient treatment programs had the
highest mean at 1.51 compared to participants from outpatient drug-free programs with
the lowest mean at 1.19. The DRLOC scale positively correlated with the Addiction
Severity Index at .301, which indicated that as addiction severity increased, scores on the
DRLOC tend to increase toward external-LOC values.
For this study, , the DRLOC scale functioned as the dependent variable. The score
obtained from the DRLOC scale served to measure the differences among men and
women who used narcotics versus stimulants. The DRLOC scale consists of 15 forced
choice items that give two statements for each item forcing the participant to choose one
of the two statements identified as A or B. Statement A equal one point and statement B
equal 2 points. The 15 items measure LOC on a continuum from internal to external.
After the participant complete the DRLOC scale, the interviewer adds the numbers
circled by the participant. The numbers circled for items 1, 3, 5, 8, 11, 14, and 15 must be
reverse coded. After recoding, the DRLOC score is computed simply by taking the mean
score of all the items. The total score is then divided by 15 (the total number of items on
the scale) to get the mean score. A score that is closer to one represents a more internally
controlled locus, and a score that is closer to two indicate a more externally controlled
locus.
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As applied to this study, people with a score closer to one is considered to have an
awareness and acceptance of positive or negative consequences resulting from their drug
use, while people with a score closer to two is considered to attribute positive or negative
consequences from drug use as actions out of their control. E. A. Hall (personal
communication, June 20, 2016) identified the variable named “flocscor” in the archival
SPSS data set as the 15-item composite mean representing DRLOC scores. Scores from
participants who identified narcotic or stimulants as their drug use at the time of
treatment are included in the sample population and analysis.
Drug use, as defined in this study are narcotics and stimulants, and served as the
independent variable that represented the two categories. This study examined the extent
by which DRLOC scores differ with narcotic use versus stimulant use. Hall’s research
identified seven categories for drug use in her study, of which alcohol, marijuana, and the
category, other, was excluded from my sample and analysis. Hall listed narcotics as a
self-contained category and in her codebook assigned code 7. The categories that consists
of cocaine, crack, amphetamine and Methamphetamine were recoded into a single
category to represent stimulant.
The second independent variable in this study was gender. As represented in
Hall’s study and listed on the initial intake form, gender comprised of two levels, male
and female. The archival SPSS data set had this variable coded as follows: male = 1,
female = 2. The importance of examining gender in this study was to determine if a class
of drugs being used by men versus women impacted DRLOC scores.
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Demographics for Hall’s DRLOC study was obtained from participants and
coded. Some of Hall’s demographics: race, education, and socioeconomic status, were
included in this study as a covariate in the primary analysis. Not addressed in Hall’s data
set was information on age. This study included age by calculating the difference
between 1996 (which was the intake interview year) and the year of birth, which was on
the demographic questionnaire. The number obtained would represent the age of the
participant at the time of treatment intake.
In Hall’s study, participants were asked to identify self by race. Hall provided a
list of seven options with assigned codes: White = 1, Black or African-American = 2,
Asian or Pacific Islander = 3, Native American = 4, Hispanic = 5, Multi-racial = 6, and
other = 7. In the archival SPSS data set the variable is f1q13 and its label. “race”.
Hall’s question about education was how many years of schooling the participant
completed. As noted in Hall’s codebook, the question was labeled “# years school
completed” and could be found in the archival SPSS dataset named flq16.
An important demographic obtained from Hall’s study and evaluated as part of
this study was socioeconomic status. As part of Hall’s archival SPSS data set
socioeconomic status named f1q23 and labeled “your 95 income range”. The range
documented in the codebook was list as under $19,000 to over $200,000. Within this
range, participants were given 19 categories to choices from.
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Research Question, Hypotheses, and Analysis Plan
The dependent variable was DRLOC scores, in which a low score indicates an
internal-LOC and a high score indicates an external-LOC. The independent variables
were primary drug (narcotic or stimulant) and gender (male or female). Of primary
interest was the effect of the primary drug on DRLOC score, but because Hall (2001)
found males had statistically significant higher DRLOC scores than females, it was
important to control for gender and examine any interaction effect between gender and
primary drug. To simplify the hypotheses that followed, the test of a specific effect
assumed statistical control for the other effects.
RQ1: To what extent do DRLOC scores differ by primary drug (narcotic vs.
stimulant), gender (male vs. female), and their interaction?
N01: There is no statistically significant difference (p > .05) in DRLOC scores
between participants whose primary drug was a narcotic versus a stimulant.
Na1: There is a statistically significant difference (p < .05) in DRLOC scores
between participants whose primary drug was a narcotic versus a stimulant.
N02: There is no statistically significant difference (p > .05) in DRLOC scores
between males and females.
Na2: There is a statistically significant difference (p < .05) in DRLOC scores
between males and females.
N03: There is no statistically significant interaction effect (p > .05) between
primary drug and gender on DRLOC scores.
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Na3: There is a statistically significant interaction effect (p < .05) between
primary drug and gender on DRLOC scores.
To test the hypotheses and answer the research question, a 2x2 full factorial
ANOVA was conducted. This helped to simultaneously test the main effect of the
primary drug, the main effect of gender, and the interaction effect. If any of the other
study variables—age, race, socioeconomic status, or education—is found to relate to
DRLOC scores, it was entered as a covariate in the primary analysis.
Threats to Validity
Hall’s sample population for the DRLOC study was recruited from the previous
study conducted by the UCLAs Integrated Substance Abuse Programs. A threat to
external validity could occur from participant’s knowledge of moving from one study to
another with researchers they are familiar with. Because of this knowledge participants’
reaction to topics presented might influence behavior because of familiarity. An
extraneous variable is the potential the participant is under the influence of stimulants or
narcotics. Active drug use could influence behavior and thought processes, thereby
effects the responses to the DRLOC scale.
Selection bias could be another threat to internal validity due to the five stages of
change and motivation associated with the process of recovery and addictive behaviors
(DiClemente, 2003; Norcross et al., 2011; Prochaska & Norcross, 2001). The five stages
of change demonstrate the level of awareness a participant has about their addictive
behaviors, and how this awareness influences their recovery (DiClemente, 2003;
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Norcross et al., 2011; Prochaska & Norcross, 2001). According to the theory of stages of
change, those who chose to participate in the study are more likely to fall in the later
stages of change compared to the first two stages of change (DiClemente, 2003; Norcross
et al., 2011; Prochaska & Norcross, 2001). The effect this could have on the study is
significant if the majority of participants are in the later stage of recovery.
Furthermore, the phenomenon of participants giving a socially appropriate
response compared to honest responses representative of their addictive behaviors and
thought processes could affect internal validity. According to Davis et al. (2014), selfreport instruments tend to move people to respond in a way that is contrary to how they
might respond if the possibility of tracking their answers existed. Davis et al. (2014)
reported the need to present oneself in a favorable way, to make a positive impression, or
to exaggerate responses to feeling socially acceptable are all concerns when
administering self-report instruments like the DRLOC scale. Davis et al. (2014) further
reported what is most important when using a self-report instrument to measure treatment
success in people with substance use disorders is the need to stay aware of a person’s
reason for treatment, as well as their need for social desirability (Davis et al., 2014).
Ethical Procedures
The UCLAs Integrated Substance Abuse Programs, Dr. Hall, the researcher of the
Feelings About Drug Use, DRLOC study, the Chair over the current study, and a
representative of Walden University’s Center for Research Quality, Institutional Review
Board agreed the need for reviewing ethical procedures for securing the dataset. The
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procedure included securing the data during its use and not sharing or using it in an
unethical way. Furthermore, we agreed I would secure the original copy of the dataset on
an external drive and stored in a locked safe. The copy used with SPSS program would
be on a secure desktop that has a secure access code. Finally, I contacted Walden’s
Center for Research Quality, Institutional Review Board to provide written permission
through the application process to move forward with obtaining and assuring the security
of the dataset. Once the study was completed, I would store the dataset for five years.
Afterward, I would delete the dataset from my hard drive and external drive. I would
send notification of this action to Dr. Hall, UCLAs Integrated Substance Abuse
Programs, and Walden’s Center for Research Quality, Institutional Review Board. A
copy of the permission forms and agreements to use the dataset is in Appendix A.
Any information that could reasonably identify participants was removed or
coded if this process had not already been completed in the dataset. This process would
include removal of participant’s name, geographical location of residence, personal
information such as telephone numbers, emails, social security numbers, medical record
numbers, driver license, photos of participants, or any other identifiers that could be used
to connect the participant with the study. For this study, one identifier was used as the
date of birth in order to obtain the age of participants at the time the study. Upon
completion of the study, results of the findings will be written and downloaded onto a
CD, placed in a sealed envelope, and then forwarded to Dr. Hall by the United States
Postal Service.
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Summary
I conduct a quantitative, pre-experimental static group comparison secondary
analysis of Hall’s (2001) study, which itself, was a follow-up on a larger study by
UCLAs Integrated Substance Abuse Programs. From Hall's data set of 553 participants, I
extract and analysis a subset of 402 participants. The total size of the subset depended on
the number of participants with non-missing data on the key study variables of DRLOC
scores, primary drug as either narcotic or stimulant, and gender. The purpose of the
current study was to examine differences in DRLOC scores between males and females
and between the two categories of primary drug. The results of this examination are
presented in Chapter 4.
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Chapter 4: Research Methodology
Introduction
The purpose of conducting this preexperimental quantitative study through
secondary analysis was to reexamine data on individuals who received treatment for their
substance use disorders. Specifically, to examine the main factorial effects of primary
drug (narcotic vs. stimulant), gender (men vs. women), and their interaction on DRLOC
score. The score generated from the DRLOC instrument is summed and then divided by
15. A score closer to one represent an internal-LOC, indicating a person is more likely to
be actively engaged, has a higher sense of self, and can make decisions independently. A
score closer to two represent an external-LOC, indicating a person more prone to
depression, anxiety, and a limited ability to cope with daily stressors (Hall, 2001).
Chapter 4 consists of a description of how the secondary data was obtained as
well as the results of the statistical analysis. Non-significant and statistically significant
results of comparisons between the three variables are provided with the use of between
subject analysis and factorial ANOVA. Reliability of the DRLOC was presented as well
as screening of targeted demographics for potential covariates. Finally, a summary of the
results presented in Chapter 5 with an introduction to Chapter 5 is provided.
Archival Dataset
The archival dataset utilized in this study was created by UCLAs Integrated
Substance Abuse Programs’ Drug Treatment Process and Drug Treatment Counselor
Practices and Effectiveness study. The sample size in UCLAs study was 666 participants
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who were diagnosed with a substance use disorder. The participants were recruited from
19 drug treatment programs in Los Angeles County. From the UCLAs Integrated
Substance Abuse Programs’ study, 553 participants agreed to participate in Hall’s (2001)
Feelings About Drug Use, DRLOC study. Hall’s goal was to measure drug-related LOC
in patients receiving treatment for substance use disorders. To conduct the current study,
Hall was contacted with a request to use the data collected from the Feelings About Drug
Use, DRLOC study. Upon agreement regarding how the data would be used and secured,
Hall provided the dataset with a codebook for the study. Upon examination of the 553
participants, a subset of 402 participants who indicated either a narcotic or stimulant as
their primary drug was identified.
Variables of Interest
The focus of the Effect Gender and Narcotic or Stimulant Abuse has on DrugRelated Locus of Control [DRLOC] (Travis, 2018) study was to determine if primary
drug use among men versus women affected the DRLOC score. The variables of interest
were DRLOC scores, primary drugs, and gender. Hall’s code for variables used in the
main dataset was used for the Effect Gender and Narcotic or Stimulant Abuse has on
DRLOC (Travis, 2018) study. The code Flocscor represented a 15-item composite score
from the DRLOC scale (flocq51 to flocq65). For ease of output, Flocscor was renamed
drloc. The variable that represented main drug treated was coded F1q8 and renamed
primary drug. Narcotics was recoded as 1. Cocaine, crack, amphetamine, and
Methamphetamine were combined and coded as 2. All other drug types were recoded as
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not applicable. The variable Male was coded 1 and female was coded 2. Other variables
of interest in this study were race, education, income, and age. F1q13 was renamed race,
f1q16 for education was renamed years of schooling, and f1q23 for income was renamed
household income to represent socioeconomic status. The dataset did not contain a
variable for age. Age was calculated by subtracting year of birth (f1q12) from 96 (the
year the data was collected), to represent age at intake.
Eligible Cases
Eligible cases were defined as cases with nonmissing data for drloc, primary drug,
and gender. Of the cases presented in Hall’s original dataset, 108 were missing drloc
scores, 34 did not identify a primary drug, and 21 did not provide a gender. There were
402 cases that had valid data and were eligible for analysis. A filter was created so that all
subsequent analyses were based only on these 402 cases.
Descriptive Statistics
To describe the sample population for this study, the age, race, socioeconomic
status, and education level of the sample population was reported. Operationalization of
demographic variables was conducted to determine potential relationship to the DRLOC
score to be reported as a covariate in the primary analysis. Of the 402 participants in the
current study, 161 (40%) were male and 241 (60%) were female. Two Hundred and
Eighty-five (70.9%) participants reported stimulants as their primary drug while 117
(29.1%) reported using narcotics as their primary drug.
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Of the 402 participants, 157 (39.1%) were White, 135 (33.6%) were
Black/African American, 16 (4%) were Asian/Pacific Islander, 5 (1.2%) were Native
American, 76 (18.9%) were Hispanic, 10 (2.5%) were multiracial, and 2 (.5%) were
identified as Other. One participant’s data was missing in the system and represented .2%
of the 402 participants. When examining age, the youngest participant was 19 and the
oldest participant was 69 (M = 35.46, SD = 8.49). The median was 34. Skewness and
kurtosis were both less than 1.0 and within acceptable range of normal distribution with
skewness at .690 and Kurtosis at .731.
Hall (2001) indicated the education level of those who participated in the study
averaged 12.2 years. The sample population for this study ranged from a minimum of 6
years to a maximum of 26 years of education. Years of education had a high kurtosis at
5.894 because one case reported 26 years; the next closest was 20. The outlier case was
recoded to 20, which brought the distribution of the variable within acceptable normal
range with kurtosis at 1.730 and skewness at .678. The normal range was a skewness of
less than the absolute value of 3 and kurtosis less than the absolute value of 7 (Kline,
2016). After recoding, the mean was 12.03, standard deviation was 2.25, and the median
was 12.
In the case of household income, this variable was coded as range because it was
an ordinal variable. The means 3.4091 is not itself valid, but it was used to state that the
average income was between $15,000 and $24,999. The minimum and maximum
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household incomes were $10,000 to over $200,000, respectively. There were 212
participants (53.5%) that had household income under $10,000.
DRLOC Reliability and Descriptive Statistics
Scores generated from the DRLOC ranged between 1 and 2. People with a score
closer to one are considered to have an awareness and acceptance of positive or negative
consequences resulting from their drug use, while people with a score closer to two are
considered to attribute positive or negative consequences from drug use as actions out of
their control (Page & Scalora, 2004). Ersche et al. (2012) demonstrated a reliability of the
DRLOC instrument at .81 for measuring thought processes. For this study, as presented
in Table 1 and Table 2, the DRLOC had good reliability at .816. Skewness and kurtosis
were within acceptable range of normal distribution.
Table 1
DRLOC Descriptive Statistics
Statistic
# of items
Cronbach’s alpha
M
Median
SD
Minimum
Maximum
Skewness
Kurtosis

Value
15
.816
1.21
1.13
.21
1.00
1.93
1.10
0.52
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Inferential Analysis
The research question examined for this study was: To what extent do DRLOC
scores differ by primary drug (narcotic vs. stimulant), gender (male vs. female), and their
interaction?
N01: There is no statistically significant difference (p > .05) in DRLOC scores
between participants whose primary drug was a narcotic versus a stimulant.
Na1: There is a statistically significant difference (p < .05) in DRLOC scores
between participants whose primary drug was a narcotic versus a stimulant.
N02: There is no statistically significant difference (p > .05) in DRLOC scores
between males and females.
Na2: There is a statistically significant difference (p < .05) in DRLOC scores
between males and females.
N03: There is no statistically significant interaction effect (p > .05) between
primary drug and gender on DRLOC scores.
Na3: There is a statistically significant interaction effect (p < .05) between
primary drug and gender on DRLOC scores.
Screening of Demographics as Covariates or Confounds
The demographic variables, education level, socioeconomic status, age and race
were screened as potential covariates or confounds. As a result of the screening,
education level, socioeconomic status, and age did not demonstrate a direct influence or
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had an effect on DRLOC scores. Therefore, the demographic variables were not included
as a covariate in the primary analysis.
Race was recoded into 4 categories because some of the original categories had
very small numbers of cases: White, African-American, Hispanic, all other. The “All
Other” category included Asian/Pacific Islander, Native American, and Multi-racial.
Levene’s Test of Equality of Error Variances was conducted to test the null hypothesis
that the error variance of the dependent variable, DRLOC score, was equal across groups.
Levene’s test was significant, meaning the groups did not have equal variance. However,
according to Tabachnick and Fidell (2007), if the ratio of the largest group variance to
that of the smallest group variance is less than 10, than it is okay. In this case the ratio
was 2.2 (.2482 divided by .1682).
Analysis of between-subjects presented in Table 2 below, demonstrated DRLOC
scores do statistically significantly differ by race, F(3, 398) = 7.07, p < .001, eta squared
= .05 (a medium size effect). Hispanics had higher DRLOC scores than both White and
African American groups.
Table 2
Effect of Race on DRLOC Scores
Race

DRLOC
M
SD

Homogeneous
Subsetsa
White
157
1.22
.22
a
African-American
135
1.16
.17
a
Hispanic
76
1.29
.25
b
All other
34
1.19
.18
a, b
a
Racial categories with the same subset letter did not statistically significantly differ.
N
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To further screen for race and its relationship with primary drug, further analysis
showed there were more African Americans in the stimulant group (n = 121) than
statistically expected (n = 95.7), and more Hispanics in the narcotic group (n = 42) than
statistically expected (n = 22.1), χ2(3, N = 402) = 49.51, p < .001, Cramer’s V = .351.
There were more female African Americans in the study (n = 94) than statistically
expected (n = 80.9), and more male Hispanics in the study (n = 43) than statistically
expected (n = 30.4), χ2(3, N = 402) = 14.71, p = .002, Cramer’s V = .191.
Because race was not independent of primary drug or gender, a preliminary
factorial ANOVA that included race was performed. There was not a statistically
significant effect for race, nor race by primary drug 2-way interaction, nor race by gender
2-way interaction, nor race by primary drug by gender 3-way interaction. Therefore, race
was not included in the final inferential analysis to test the hypotheses and answer the
research questions. As noted in Table 12, Levene’s test was significant, but the ratio of
largest group variance to smallest group variance was within acceptable range to assume
homogeneity of error variance (.2352 divided by .1652 = 2.04).
Factorial ANOVA Results
A 2 (gender) X 2 (primary drug) factorial ANOVA was conducted. Levene’s test
was significant, but the ratio of largest group variance to smallest group variance was
within acceptable range to assume homogeneity of error variance (.2352 divided by .1652
= 2.04). Table 3 shows a between-subject analysis of gender and primary drugs that
demonstrated the main effect of gender was not significant. Further analysis presented in
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Table 4, showed males (1.242) and females (1.276) had relatively equal means on
DRLOC. The main effect of primary drug was significant and the interaction was
significant. The narcotic group had higher mean (1.358) for DRLOC scores than the
stimulant group (1.159). Because the interaction was significant, it is invalid to solely
rely on the main effects of gender and primary drug to understand differences on DRLOC
scores. Instead, the focus needed to be on interpreting the interaction. As detailed in
Table 4, and displayed in Figure 1, females in the narcotic group had higher DRLOC
scores than males, but females in the stimulant group had lower DRLOC scores than
males.
Table 3
Factorial ANOVA Results of Gender and Primary Drug on DRLOC Scores
Source

SS
0.094
3.159
0.380
14.013
17.694

Gender
Primary drug
Gender*Primary drug
Error
Total

df
1
1
1
398
401

MS
0.094
3.159
0.380
0.035

F
2.672
89.722
10.806

p
.103
<.001
.001

ηp2
.007
.184
.026

Table 4
DRLOC Scores by Gender and Primary Drug

Group
Narcotic
Stimulant
Total

N
65
96
161

Male
M
1.31
1.18
1.23

SD
.24
.16
.21

N
52
189
241

Female
M
1.41
1.14
1.20

SD
.23
.17
.21

N
117
285
402

Total
M
1.35
1.15
1.21

SD
.24
.17
.21

108
1.50

1.41
DRLOC Score

1.40

1.30

1.31

Male
Female

1.20

1.18
1.14

1.10
Narcotic

Stimulant

Figure 1. Interaction effect of gender and primary drug on DRLOC scores.
Summary
Archival data of 402 eligible cases were obtained from the UCLAs Integrated
Substance Abuse Programs’ Drug Treatment Process and Drug Treatment Counselor
Practices and Effectiveness study. The 15-item DRLOC scale, the dependent variable,
had a Cronbach’s alpha of .816 and was within normal distribution parameters. Hispanics
had higher DRLOC scores than Whites and African-Americans. African-Americans were
overrepresented in the stimulant group and Hispanics were overrepresented in the
narcotic group. Also, female African-Americans and male Hispanics were
overrepresented. Despite the confounds around the race variable, a preliminary factorial
ANOVA of race, gender, and primary drug found no significant main or interaction
effects involving race, so it was excluded from further analysis. In the factorial ANOVA
of gender and primary drug on DRLOC scores to test the hypotheses and answer the

109
research question, primary drug and the gender by primary drug interaction effects were
significant. While, overall, the narcotic group had higher DRLOC scores than the
stimulant group, the interaction manifested as females in the narcotic group having higher
DRLOC scores than males, with females in the stimulant group having lower DRLOC
scores than males.
Further interpretation and conclusion of the findings, social change implications
and future considerations of potential implementation of the DRLOC instrument as part
of the treatment process was discussed in chapter 5. To conclude, the limitations of this
study and recommendations for future research with the DRLOC instrument were also
presented in chapter 5.
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Chapter 5: Discussion
Purpose Statement
The purpose of this study was to examine if narcotic or stimulant use among men
and women effect the DRLOC score and to determine if it is useful to implement the
DRLOC scale as an individualized instrument to be included in the treatment process.
Implementing the DRLOC scale at the time of admission, during treatment, and toward
the end of treatment could potentially help measure several outcomes, including the
ability to measure patients’ progress in treatment through personal awareness and shifts
in thought processes and behaviors, or the lack thereof. Additionally, the DRLOC score
could provide a reasonable understanding of the minimal progress achieved and
determine the appropriate intervention needed that coincide with the patient’s DRLOC
score.
The focus of this study was to examine the effect gender and primary drug had on
DRLOC. Conducting an extensive literature review, no recent research was discovered
which focused on LOC and narcotics, LOC and stimulants, or LOC with narcotic and
stimulants.
There were limited numbers of assessment tools used for measuring drug-related
disorders and LOC. The original I-E LOC scale measured individuals’ beliefs in whether
they could control their consumption of alcohol and did not focus on drug abuse (Rotter
& Mulry, 1965). Calicchia (1974) used the I-E LOC scale to measure LOC and heroin
usage. Hall (2001) developed the DRLOC scale to focus specifically on drug abuse
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among people in treatment programs. Ersche et al. (2012) studied the reliability of the
DRLOC scale and reported the DRLOC scale to be an effective assessment tool for
measuring LOC in people with substance use disorders.
The DRLOC scale consists of 15 forced choice items that give two statements for
each item, which forces participants to choose one of the two statements identified as
either A or B. Statement A equals one point and statement B equals two points. The 15
items measure LOC on a continuum from internal to external. After the participant
complete the DRLOC scale, the interviewer adds the numbers circled by the participant.
The numbers circled for items 1, 3, 5, 8, 11, 14, and 15 must be reverse coded. After
recoding, the DRLOC score is computed by taking the mean score of all items. The total
score is then divided by 15 (the total number of items on the scale) to get the mean score.
A score that is closer to one represents a more internally controlled locus and a score that
is closer to two indicates a more externally controlled locus.
The DRLOC scale was the latest LOC instrument in the field of social science.
Hall’s (2001) analysis of the DRLOC instrument found α = .81. Hall measured internal
consistency by applying Cronbach’s alpha and the split-half procedure using the
Spearman-Brown Prophecy formula. Hall explained the study was large and hindered the
procedure for test-retest reliability and examined other measures to test convergent
validity by examining correlations of scores. This included participants’ DRLOC scores
and Addiction Severity Index scores which were positively correlated (r = .301 p <.00).
This demonstrated that high scores generated from the Addiction Severity Test (except
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for the subscale Medical) correlated with a high score on the DRLOC. It should be noted
that of the seven domains in the Addiction Severity Index scale (medical, employment,
alcohol and drugs, legal, family and social relationships, and psychiatric) the subscale of
alcohol and drugs demonstrated the highest correlations with a score of .283.
Participant Selection
The purpose of conducting a secondary analysis was to reexamine data on
individuals who received treatment for their substance use disorder. Specifically, the
purpose was to examine the main factorial effects of primary drug (narcotic vs.
stimulant), gender (men vs. women), and their interaction. This was accomplished by reexamining secondary data generated by the UCLAs Integrated Substance Abuse
Programs’ Drug Treatment Process and Drug Treatment Counselor Practices and
Effectiveness study. The sample size in the UCLAs study was 666 participants diagnosed
with substance use disorders from 19 drug treatment programs. From the UCLAs
Integrated Substance Abuse Programs’ study, 553 participants agreed to participate in
Hall’s (2001) Feelings About Drug Use, DRLOC study. From Hall’s study, 402
participants’ data was used for the Effect Gender and Narcotic or Stimulant Abuse has on
DRLOC study. Of the 402 participants, 285 reported their drug of choice to be stimulants
and 117 reported their drug of choice to be narcotics.
The study consisted of 157 (39.1%) White, 135 (33.6%) were Black/African
American, 16 (4%) were Asia/Pacific Islander, 5 (1.2%) were Native American, 76
(18.9%) were Hispanic, 10 (2.5%) were multiracial, and 2 (.5%) were identified as Other.

113
One participant’s data was missing in the system and represented .2% of the 402
participants. The youngest participant was 19 and the oldest participant was 69 (M =
35.46, SD = 8.49). The median was 34. Skewness and Kurtosis were both less than 1.0
and within acceptable range of normal distribution with skewness at .690 and Kurtosis at
.731.
Hall’s (2001) report indicated the education level of those who participated in the
UCLAs study averaged 12.2 years. The sample population for the Effect Gender and
Narcotic or Stimulant Abuse has on DRLOC (Travis, 2018) study ranged from a
minimum of 6 years and a maximum of 26 years of education. Years of education had a
high kurtosis at 5.894 because one case reported 26 years; the next closest was 20. The
outlier case was recoded to 20, which brought the distribution of the variable within
acceptable normal range with kurtosis at 1.730 and Skewness at .678. Normal range is
skewness less than the absolute value of 3 and kurtosis less than the absolute value of 7
(Kline, 2016). After recoding, the mean was 12.03, standard deviation was 2.25, and the
median was 12.
In the case of household income, this variable was coded as range because it is an
ordinal variable. The mean 3.4091 is not itself valid, but it was used to state that the
average income was between $15,000 and $24,999. The minimum household income was
under $10,000 and the maximum was over $200,000. There were 212 cases (53.5%) that
had a household income under $10,000.
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Research
The research question examined for this study was: To what extent do DRLOC
scores differ by primary drug (narcotic vs. stimulant), gender (male vs. female), and their
interaction?
N01: There is no statistically significant difference (p > .05) in DRLOC scores
between participants whose primary drug was a narcotic versus a stimulant.
Na1: There is a statistically significant difference (p < .05) in DRLOC scores
between participants whose primary drug was a narcotic versus a stimulant.
N02: There is no statistically significant difference (p > .05) in DRLOC scores
between males and females.
Na2: There is a statistically significant difference (p < .05) in DRLOC scores
between males and females.
N03: There is no statistically significant interaction effect (p > .05) between
primary drug and gender on DRLOC scores.
Na3: There is a statistically significant interaction effect (p < .05) between
primary drug and gender on DRLOC scores.
Screening of Demographics as Covariates or Confounds
The demographic variables, education level, socioeconomic status, age and race
were screened as potential covariates or confounds. As a result of the screening,
education level, socioeconomic status, and age did not demonstrate a direct influence or
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had an effect on DRLOC scores. Therefore, the demographic variables were not included
as a covariate in the primary analysis.
Race was recoded into 4 categories because some of the original categories had
very small numbers of cases: White, African-American, Hispanic, all other. The “All
Other” category includes Asian/Pacific Islander, Native American, and Multi-racial.
Levene’s Test of Equality of Error Variances was conducted to test the null hypothesis
that the error variance of the dependent variable, DRLOC score, was equal across groups.
Levene’s test was significant, meaning the groups did not have equal variance. However,
according to Tabachnick and Fidell (2007), if the ratio of the largest group variance to
that of the smallest group variance is less than 10, than it is okay. In this case the ratio
was 2.2 (.2482 divided by .1682).
Analysis of between-subjects demonstrated DRLOC scores do statistically
significantly differ by race, F(3, 398) = 7.07, p < .001, eta squared = .05 (a medium size
effect). Hispanics had higher DRLOC scores than both White and African American
groups.
To further screen for race and its relationship with primary drug, further analysis
showed there were more African Americans in the stimulant group (n = 121) than
statistically expected (n = 95.7), and more Hispanics in the narcotic group (n = 42) than
statistically expected (n = 22.1), χ2(3, N = 402) = 49.51, p < .001, Cramer’s V = .351.
There were more female African Americans in the study (n = 94) than statistically
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expected (n = 80.9), and more male Hispanics in the study (n = 43) than statistically
expected (n = 30.4), χ2(3, N = 402) = 14.71, p = .002, Cramer’s V = .191.
Because race was not independent of primary drug or gender, a preliminary
factorial ANOVA that included race was performed There was not a statistically
significant effect for race, nor race by primary drug 2-way interaction, nor race by gender
2-way interaction, nor race by primary drug by gender 3-way interaction. Therefore, race
was not included in the final inferential analysis to test the hypotheses and answer the
research questions. As noted in Table 12, Levene’s test is significant, but the ratio of
largest group variance to smallest group variance was within acceptable range to assume
homogeneity of error variance (.2352 divided by .1652 = 2.04).
Factorial ANOVA Results
A 2 (gender) X 2 (primary drug) factorial ANOVA was conducted. Levene’s test
was significant, but the ratio of largest group variance to smallest group variance were
within acceptable range to assume homogeneity of error variance (.2352 divided by .1652
= 2.04). A between-subject analysis of gender and primary drugs that demonstrated the
main effect of gender was not significant. Further analysis presented, showed males
(1.242) and females (1.276) had relatively equal means on DRLOC. The main effect of
primary drug was significant and the interaction was significant. The narcotic group had
higher mean (1.358) for DRLOC scores than the stimulant group (1.159). Because the
interaction was significant, it is invalid to solely rely on the main effects of gender and
primary drug to understand differences on DRLOC scores. Instead, the focus needs to be
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on interpreting the interaction. Females in the narcotic group had higher DRLOC scores
than males, but females in the stimulant group had lower DRLOC scores than males.

Limitations of the Study
A limitation identified in the Feelings About Drug Use, DRLOC study derived
from how the sample population was generated. Participants from the original study were
populated through a stratified, random selection of patients from 19 different types of
alcohol and drug treatment programs. Selecting narcotics and stimulants as variables in
the Effect Gender and Narcotic or Stimulant Abuse has on DRLOC (Travis, 2018) study
provided more consistency with drug treatment by excluding alcohol and other types of
drug abuse from the data. However, treatment philosophies and length of treatment still
presented limitations with consistency within the sample population.
Other limitations were reflected in reading and writing abilities of the participants
with education levels ranging from a minimum of 6 years and a maximum of 26 years of
education. Participant’s education level in the Effect Gender and Narcotics or Stimulant
Abuse has on DRLOC (Travis, 2018) study averaged 12 years of education.
Extraneous and confounding variables reflect biopsychosocial triggers in the
environment, such as the possibility that participants could have been under the influence
of drugs during the study. The influences of foreign chemicals introduced into the body
have an effect on behaviors and thought processes (APA, 2013) and could affect the
response given to questions on the DRLOC instrument.
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Recommendations
The focus of the Effect Gender and Narcotics or Stimulant Abuse has on DRLOC
(Travis, 2018) study was to examine if narcotic or stimulant use among men and women
affect the DRLOC score, if gender affects the DRLOC score, and if the interactions
between drug use and gender is significant. It is recommended, from the results of the
Effect Gender and Narcotics or Stimulant Abuse has on DRLOC (Travis, 2018) study,
that the DRLOC scale, as a viable instrument for measuring drug-related LOC and
interactions between drug use and gender, be included as part of a program’s treatment
protocol.
Individualize treatment is needed due to gender differences as referenced by the
scores and specific drugs use reflected in the Effect Gender and Narcotics or Stimulant
Abuse has on DRLOC (Travis, 2018) study, which demonstrated males in the narcotic
group had lower DRLOC scores than females, but males in the stimulant group had
higher DRLOC scores than females. The results of DRLOC scores validates there are
differences related to gender and primary drug abuse (Shannon et al., 2014) and
differences in patterns of drug use (Lev-Ran et al., 2013; Samuelsson, 2015).
Administering the DRLOC scale at admittance into treatment programs, during
treatment, and at discharge from a program is recommended and could help to measure
patient’s thought processes and behaviors related to drug activities throughout treatment.
Administrating the DRLOC scale at the beginning of treatment could also help in
predicting patient’s willingness to fully engage in treatment (Page and Scalora, 2004),
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which would allow practitioners to meet patients where they are in their stage of change
toward recovery. The DRLOC score could also help in determining which evidencebased treatment fits the individual’s needs and whether or not this intervention worked.
When treatment programs implement the DRLOC scale as part of the treatment process,
admittance score that represents External-LOC at the beginning of treatment and shifts to
Internal-LOC at end of treatment would demonstrate effective interventions, while a
score from Internal-LOC to External-LOC would demonstrate ineffective interventions
(Page and Scalora, 2004).
Further recommendation for a longitudinal study looking at gender, primary drug
of choice, DRLOC scores obtained throughout treatment, and a specific evidence-based
intervention to determine if DRLOC scores could measure shifts in behaviors and thought
progress is needed. For example, administering the DRLOC in specific treatment
programs, such as methadone maintenance treatment programs, where a sample
population identifies narcotics as their primary drug of choice, and where each patient is
being provided methadone as part of the treatment protocol, can serve as the next step for
examining the effectiveness of the DRLOC scale and its importance in the field of
addiction and treatment protocol.
Social Implications
The Effect Gender and Narcotic or Stimulant Abuse has on DRLOC (Travis,
2018) study demonstrated the importance of understanding the interaction between
gender and primary drugs influence on LOC. Social implications for practitioners
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becoming awareness of this interaction would be helpful with treatment. Social
implications for treatment programs that administer the DRLOC scale could be beneficial
for measuring treatment success on the part of the practitioners and patient. Clinicians in
multiple human service fields and community organizations could benefit by knowing a
patient’s DRLOC score and then align the score with appropriate evidence-based
interventions (National Registry of Evidence-based Programs and Practices, 2016).
Social implication for utilizing the DRLOC score to educate patients about their
LOC could help patients become aware of their behavior and thought processes. Patients
could gain a better understanding of how their ongoing drug use is connected to how they
view their current situation and prior experiences in life and what might be their triggers.
This knowledge of understanding how drug use and LOC are connected to triggers could
help patients develop coping skills to recognize and resist triggers for a better quality of
life.
Social implications for utilizing a DRLOC instrument for both professionals and
patients would help to minimize stigma in treatment settings. Practitioners who
administer a LOC instrument as part of family therapy with each family member could
see amongst family members a better understanding of a loved one’s addictive behaviors
and levels of control when each family member is aware of their own LOC and how this
impacts their interactions with others (Foon, 1986). Being aware of one’s LOC score may
help family members change their perception and the stigma associated with addictions
(Foon, 1986) once they understand their love one’s DRLOC score.
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Social implications may extend to the general public becoming better educated
about LOC by understanding their personal score could help the public recognize their
thought processes associated with their decision making and daily responses to events
and situations. This recognition of how LOC impacts every person’s behavior could
result in positive shifts in how the public view and treat people with a substance use
disorder and their DRLOC scores.
Conclusion
The results of the Effect Gender and Narcotics or Stimulant Abuse has on the
DRLOC (Travis, 2018) study, in which a majority of participants were identified as
stimulant users, coincide with the research conducted in the addiction field. CDADP
(2013) found Methamphetamine was the most commonly reported primary drug of
choice in the state, at a rate 13% higher than heroin, and admission rates of 48,345
patients into treatment for stimulant abuse were higher compared to 38,785 admissions
for narcotic abuse (SAMHSA, 2016d). These statistics underscore a need to understand
the importance of structuring treatment with evidence-based interventions by first
identifying what the individualized needs are for the patient. The Effect Gender and
Narcotics or Stimulant Abuse has on the DRLOC (Travis, 2018) study demonstrated the
importance of identifying a patient’s DRLOC score in order to select the best treatment
intervention for the individual.
A more important understanding of gender is needed when treating patients.
Conflicting ideologies of treating all men and women as equal, compared to addressing
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gender-specific needs, is a dilemma for some treatment programs because men and
women are different biopsychosocially (Lev-Ran et al., 2013; Samuelsson, 2015). As
demonstrated in the Effect of Gender and Narcotics or Stimulant Abuse has on the
DRLOC (Travis, 2018), DRLOC scores related to gender bared no significant difference.
However, when examining the interaction between gender and primary drug of choice,
significant differences occurred. The results support the importance of men and women
who used narcotics or stimulants benefiting from learning their DRLOC score and being
provided with evidence-based treatment that addresses their specific drug of choice,
thought processes, and behaviors.
If administered throughout the treatment process, the DRLOC instrument could
potentially help measure several outcomes: The ability to measure patient’s progress
throughout treatment through personal awareness and shifts in thought processes and
behaviors, or the lack thereof. It could provide a reasonable understanding of the minimal
progress achieved. Most important, the DRLOC instrument could determine the
appropriate interventions needed that coincide with the patient’s LOC score.
In closing, the practice of administering the DRLOC instrument at the beginning
of treatment, during treatment, and at the end of treatment (Pasareanu et al., 2015) should
be part of the treatment protocol along with appropriate patient-centered, evidence-based
interventions that meet the needs of the individual.
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Appendix A: Permission to use the Drug-Related Locus of Control Dataset

From: yolanda travis [truncated]

Sent: Monday, March 16, 2015 7:24 AM
To: [truncated]
Subject: Doctoral Permission to use the DRLOC

YOLANDA RENE TRAVIS
[truncated]

March 16, 2015

Dr. Elizabeth A. Hall,
[truncated]

Dear Dr. Hall,

My name is Yolanda Rene՜ Travis. I am a doctoral student at Walden University located in Minneapolis,
Minnesota. I am currently working on my dissertation and I am ready to start my research. I will be
examining The Relationship Between Impulsivity, Locus of Control, and Addictive Behaviors Among
People in Methadone Maintenance Treatment Programs.
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I read your article, Feelings About Drug Use, Drug-Related Locus of Control. I am very excited that you
have developed an individualized instrument that targets drug use across modalities. My interest is to focus
on patients diagnosed with Opioid Use Disorder. Your instrument will help my research by measuring
locus of control over sustained abstinence or ongoing drug use while receiving narcotic therapy at
Methadone Maintenance Treatment Programs located in Central and Northern California. The DRLOC will
serve as an effective assessment tool for my research in lieu of having to develop my own instrument to
measure locus of control in this population.

I would like your permission to use the DRLOC scale in my research to measure internal and external locus
of control. If I have your permission to use this instrument, please let me know as soon as possible.

My long-term goal is to be a psychologist specializing in addictive behaviors. I look forward to your
response.

Sincerely,

Yolanda Rene′ Travis
[truncated]

From: [truncated]
To: [truncated]
CC: [truncated]
Subject: RE: Doctoral Permission to use the DRLOC
Date: Mon, 16 Mar 2015 13:39:55 -0700
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Yes, you have my permission to use the DRLOC. It sounds like a fascinating study. Good luck and please
let me know what you find.

--Betsy

Elizabeth A. Hall, Ph.D.
[truncated]

UCLA HEALTH SCIENCES IMPORTANT WARNING: This email (and any attachments) is only
intended for the use of the person or entity to which it is addressed, and may contain information that is
privileged and confidential. You, the recipient, are obligated to maintain it in a safe, secure and confidential
manner. Unauthorized redisclosure or failure to maintain confidentiality may subject you to federal and
state penalties. If you are not the intended recipient, please immediately notify us by return email, and
delete this message from your computer.
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Appendix B: Drug-Related Locus of Control Scale
Drug-Related Locus of Control (DRLOC)
Now, I’m going to ask you about your feelings about drug use. I’m going to read two statements, Statement
A and Statement B, and ask you to choose the one that best describes how you feel now.
(CIRCLE ONE NUMBER FOR EACH STATEMENT)
1.

A. I feel so helpless in some situations that I need to get high..........................................................1
B. Abstinence is just a matter of deciding that I no longer want to use drugs...................................2

2.

A. I have the strength to withstand pressures at work or home.........................................................1
B. Trouble at work or home drives me to use drugs..........................................................................2

3.

A. Without the right breaks you cannot stay clean............................................................................1
B. Drug abusers who are not successful in curbing their drug use often have not taken advantage
of help that is available.......................................................................................................................2

4.

A. There is no such thing as an irresistible temptation to use drugs..................................................1
B. Many times there are circumstances that force you to use drugs..................................................2

5.

A. I get so upset over small arguments that they cause me to use drugs...........................................1
B. I can usually handle arguments without using drugs.....................................................................2

6.

A. Successfully kicking substance abuse is a matter of hard work, luck has little or
nothing to do with it………………………………………………………...………………………1
B. Staying clean depends mainly on things going right for you........................................................2

7.

A. When I am at a party where others are using, I can avoid taking drugs........................................1
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B. It is impossible for me to resist drugs if I am at a party where others are using...........................2

8.

A. I feel powerless to prevent myself from using drugs when I am anxious or unhappy..................1
B. If I really wanted to, I could stop using drugs...............................................................................2

9.

A. It is easy for me to have a good time when I am sober.................................................................1
B. I cannot feel good unless I am high...............................................................................................2

10.

A. I have control over my drug use behaviors...................................................................................1
B. I feel completely helpless when it comes to resisting drugs..........................................................2

11.

A. Sometimes I cannot understand how people can control their drug use.......................................1
B. There is a direct connection between how hard people try and how successful they are
in stopping their drug use...................................................................................................................2

12.

A. I can overcome my urge to use drugs............................................................................................1
B. Once I start to use drugs I can’t stop.............................................................................................2

13.

A. Drugs aren’t necessary in order to solve my problems.................................................................1
B. I just cannot handle my problems unless I get high first...............................................................2

14.

A. Most of the time I can’t understand why I continue to use drugs.................................................1
B. In the long run I am responsible for my drug problems................................................................2

15.

A. Taking drugs is my favorite form of entertainment......................................................................1
B. It wouldn’t bother me if I could never use drugs again............................................ ....................2
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SCORING: FEELINGS ABOUT DRUG USE
Drug-Related Locus of Control (DRLOC)
The Drug-Related Locus of Control scale is a 15-item, forced-choice measure of drug-use
control expectancies in a variety of drug-use-related situations. The scoring procedures
below are designed so that clients with a more internal locus of control would produce
scores nearer to 1, while those with a more external locus of control would produce
scores nearer to 2. To produce this result, Items 1, 3, 5, 8, 11, 14, and 15 must be reverse
coded. After recoding, the DRLOC score is computed simply by taking the mean score of
all the items.

